EN

基本情報

研究

社会活動

その他の活動

佐藤 太郎

Satou Tarou

医学系研究科,寄附講座教授

論文

  • A phase II trial of dose-reducednab-paclitaxel for patients with previously treated, advanced or recurrent gastric cancer (OGSG 1302),Shigeyuki Tamura,Hirokazu Taniguchi,Kazuhiro Nishikawa,Hiroshi Imamura,Junya Fujita,Atsushi Takeno,Jin Matsuyama,Yutaka Kimura,Junji Kawada,Motohiro Hirao,Masashi Hirota,Kazumasa Fujitani,Yukinori Kurokawa,Daisuke Sakai,Hisato Kawakami,Toshio Shimokawa,Taroh Satoh,INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY,SPRINGER JAPAN KK,Vol. 25,No. 12,p. 2035-2043,2020年12月,研究論文(学術雑誌)
  • A phase II trial of dose-reduced nab-paclitaxel for patients with previously treated, advanced or recurrent gastric cancer (OGSG 1302).,Shigeyuki Tamura,Hirokazu Taniguchi,Kazuhiro Nishikawa,Hiroshi Imamura,Junya Fujita,Atsushi Takeno,Jin Matsuyama,Yutaka Kimura,Junji Kawada,Motohiro Hirao,Masashi Hirota,Kazumasa Fujitani,Yukinori Kurokawa,Daisuke Sakai,Hisato Kawakami,Toshio Shimokawa,Taroh Satoh,International journal of clinical oncology,Vol. 25,No. 12,p. 2035-2043,2020年12月,研究論文(学術雑誌)
  • Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study,Toshifumi Yamaguchi,Atsuo Takashima,Kengo Nagashima,Masanori Terashima,Masaki Aizawa,Manabu Ohashi,Ryo Tanaka,Tatsuya Yamada,Takahiro Kinoshita,Hisayuki Matsushita,Koshiro Ishiyama,Kei Hosoda,Yasuhiro Yuasa,Shusuke Haruta,Naoki Kakihara,Kazuhiro Nishikawa,Gen Yunome,Taroh Satoh,Takeo Fukagawa,Hitoshi Katai,Narikazu Boku,Gastric Cancer,Springer Science and Business Media LLC,2020年11月11日,研究論文(学術雑誌)
  • Impact of sarcopenia in patients with advanced or recurrent colorectal cancer treated with regorafenib,Yasushi Murachi,Daisuke Sakai,Jun Koseki,Chiaki Inagaki,Naohiro Nishida,Toshifumi Yamaguchi,Taroh Satoh,International Journal of Clinical Oncology,Springer Science and Business Media LLC,2020年10月26日,研究論文(学術雑誌)
  • 組織常駐型メモリーT細胞は大腸癌患者の生存率を予測するマーカーとして有用である,北風 雅敏,今野 雅允,浅井 歩,藤野 志季,荻野 崇之,高橋 秀和,三吉 範克,植村 守,佐藤 太郎,水島 恒和,土岐 祐一郎,江口 英利,石井 秀始,日本癌学会総会記事,日本癌学会,Vol. 79回,p. OJ14-3,2020年10月
  • 大腸癌における新規EMT誘導遺伝子の同定,西田 尚弘,石川 慧,坂井 大介,山口 敏史,藤野 志季,荻野 崇之,三吉 範克,高橋 秀和,植村 守,水島 恒和,佐藤 太郎,森 正樹,江口 英利,土岐 祐一郎,日本癌学会総会記事,日本癌学会,Vol. 79回,p. PE10-6,2020年10月
  • PhaseIIStudy of Panitumumab Monotherapy inChemotherapy-NaiveFrail or Elderly Patients with UnresectableRAS Wild-TypeColorectal Cancer:OGSG1602,Tetsuji Terazawa,Takeshi Kato,Masahiro Goto,Katsuya Ohta,Shingo Noura,Hironaga Satake,Yoshinori Kagawa,Hisato Kawakami,Hiroko Hasegawa,Kazuhiro Yanagihara,Tatsushi Shingai,Ken Nakata,Masahito Kotaka,Masayuki Hiraki,Ken Konishi,Shiro Nakae,Daisuke Sakai,Yukinori Kurokawa,Toshio Shimokawa,Taroh Satoh,ONCOLOGIST,WILEY,2020年09月,研究論文(学術雑誌)
  • Comparison of S-1-cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials.,Hisato Kawakami,Kazumasa Fujitani,Jin Matsuyama,Yusuke Akamaru,Shigeyuki Tamura,Shunji Endo,Yutaka Kimura,Youichi Makari,Takao Tamura,Naotoshi Sugimoto,Daisuke Sakai,Toshimasa Tsujinaka,Masahiro Goto,Yukinori Kurokawa,Toshio Shimokawa,Taroh Satoh,International journal of clinical oncology,Vol. 25,No. 9,p. 1635-1643,2020年09月,研究論文(学術雑誌)
  • Impact of sex and histology on the therapeutic effects of fluoropyrimidines and oxaliplatin plus bevacizumab for patients with metastatic colorectal cancer in the SOFT trial,Yasuhide Yamada,Kei Muro,Keiichi Takahashi,Hideo Baba,Yoshito Komatsu,Taroh Satoh,Masahiro Goto,Hideyuki Mishima,Masahiko Watanabe,Yuh Sakata,Satoshi Morita,Yasuhiro Shimada,Naruhito Takenaka,Tadashi Hirooka,Kenichi Sugihara,Global Health & Medicine,National Center for Global Health and Medicine (JST),Vol. 2,No. 4,p. 240-246,2020年08月31日,研究論文(学術雑誌)
  • Docetaxel plus S-1 versus cisplatin plus S-1 in unresectable gastric cancer without measurable lesions: a randomized phase II trial (HERBIS-3).,Yukinori Kurokawa,Jin Matsuyama,Kazuhiro Nishikawa,Atsushi Takeno,Yutaka Kimura,Kazumasa Fujitani,Ryohei Kawabata,Yoichi Makari,Tetsuji Terazawa,Hisato Kawakami,Daisuke Sakai,Toshio Shimokawa,Taroh Satoh,Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,2020年08月10日,研究論文(学術雑誌)
  • Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study).,Masahito Kotaka,Shigeyoshi Iwamoto,Hironaga Satake,Daisuke Sakai,Toshihiro Kudo,Mutsumi Fukunaga,Ken Konishi,Yoshihito Ide,Taro Ikumoto,Akihito Tsuji,Yasushi Sano,Takeshi Kato,Naotoshi Sugimoto,Taroh Satoh,Akiyoshi Kanazawa,Takayasu Kurata,Takeharu Yamanaka,Naohiro Tomita,International journal of clinical oncology,Vol. 25,No. 8,p. 1515-1522,2020年08月,研究論文(学術雑誌)
  • Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G).,Daisuke Sakai,Hiroya Taniguchi,Naotoshi Sugimoto,Takao Tamura,Tomohiro Nishina,Hiroki Hara,Taito Esaki,Tadamichi Denda,Takeshi Sakamoto,Hiroyuki Okuda,Taroh Satoh,Takahiro Tsushima,Akitaka Makiyama,Takashi Tsuda,Ayumu Hosokawa,Hidekazu Kuramochi,Shinya Tokunaga,Toshikazu Moriwaki,Hisateru Yasui,Hiroyasu Ishida,Akihito Tsuji,Satoshi Otsu,Hozumi Shimokawa,Eishi Baba,Mikio Sato,Shigemi Matsumoto,Yukinori Ozaki,Katsunori Shinozaki,Hiroshi Tamagawa,Masahiro Goto,Shigenori Kadowaki,Hirofumi Fujii,Yasuhiro Koh,Kentaro Yamazaki,Shuichi Hironaka,Junji Kishimoto,Narikazu Boku,Ichinosuke Hyodo,Kei Muro,European journal of cancer (Oxford, England : 1990),Vol. 135,p. 11-21,2020年08月,研究論文(学術雑誌)
  • Multicentre biomarker cohort study on the efficacy of nivolumab treatment for gastric cancer.,Takaomi Hagi,Yukinori Kurokawa,Ryohei Kawabata,Takeshi Omori,Jin Matsuyama,Kazumasa Fujitani,Motohiro Hirao,Yusuke Akamaru,Tsuyoshi Takahashi,Makoto Yamasaki,Taroh Satoh,Hidetoshi Eguchi,Yuichiro Doki,British journal of cancer,Vol. 123,No. 6,p. 965-972,2020年07月03日,研究論文(学術雑誌)
  • Phase II study of 5-fluorouracil-leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802).,Takashi Ohta,Takeshi Kato,Hisato Kawakami,Yasuhiro Miyake,Masahiro Goto,Shigeyoshi Iwamoto,Toshio Otsuji,Masato Nakamura,Naotoshi Sugimoto,Shu Okamura,Masahito Kotaka,Masaki Tsujie,Yukihiko Tokunaga,Hideyuki Mishima,Taishi Hata,Toshio Shimokawa,Yukinori Kurokawa,Taroh Satoh,International journal of clinical oncology,Vol. 25,No. 7,p. 1291-1298,2020年07月,研究論文(学術雑誌)
  • Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy.,Satoru Iwasa,Toshihiro Kudo,Daisuke Takahari,Hiroki Hara,Ken Kato,Taroh Satoh,International journal of clinical oncology,Vol. 25,No. 7,p. 1223-1232,2020年07月,研究論文(学術雑誌)
  • Correction to: Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy.,Satoru Iwasa,Toshihiro Kudo,Daisuke Takahari,Hiroki Hara,Ken Kato,Taroh Satoh,International journal of clinical oncology,Vol. 25,No. 7,p. 1233-1233,2020年07月,研究論文(学術雑誌)
  • Controlling lymph node micrometastases by neoadjuvant chemotherapy affects the prognosis in advanced esophageal squamous cell carcinoma.,Yoko Hiraki,Yutaka Kimura,Motohiro Imano,Hiroaki Kato,Mitsuru Iwama,Osamu Shiraishi,Atsushi Yasuda,Masayuki Shinkai,Tomoki Makino,Masaaki Motoori,Makoto Yamasaki,Hiroshi Miyata,Takao Satou,Taroh Satoh,Hiroshi Furukawa,Masahiko Yano,Yuichiro Doki,Takushi Yasuda,Surgery today,Vol. 51,No. 1,p. 118-126,2020年06月28日,研究論文(学術雑誌)
  • Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002).,Kazumasa Fujitani,Shigeyuki Tamura,Yutaka Kimura,Jin Matsuyama,Hiroshi Imamura,Kazuyoshi Yamamoto,Junya Fujita,Shohei Iijima,Shugo Ueda,Yukinori Kurokawa,Toshio Shimokawa,Taroh Satoh,Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,Vol. 23,No. 3,p. 520-530,2020年05月,研究論文(学術雑誌)
  • A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.,Li-Tzong Chen,Taroh Satoh,Min-Hee Ryu,Yee Chao,Ken Kato,Hyun Cheol Chung,Jen-Shi Chen,Kei Muro,Won Ki Kang,Kun-Huei Yeh,Takaki Yoshikawa,Sang Cheul Oh,Li-Yuan Bai,Takao Tamura,Keun-Wook Lee,Yasuo Hamamoto,Jong Gwang Kim,Keisho Chin,Do-Youn Oh,Keiko Minashi,Jae Yong Cho,Masahiro Tsuda,Hiroki Sameshima,Yoon-Koo Kang,Narikazu Boku,Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,Vol. 23,No. 3,p. 510-519,2020年05月,研究論文(学術雑誌)
  • Convolutional Neural Network Can Recognize Drug Resistance of Single Cancer Cells.,Kiminori Yanagisawa,Masayasu Toratani,Ayumu Asai,Masamitsu Konno,Hirohiko Niioka,Tsunekazu Mizushima,Taroh Satoh,Jun Miyake,Kazuhiko Ogawa,Andrea Vecchione,Yuichiro Doki,Hidetoshi Eguchi,Hideshi Ishii,International journal of molecular sciences,Vol. 21,No. 9,2020年04月30日,研究論文(学術雑誌)
  • A Phase II Study of Perioperative Capecitabine plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601).,Tetsuji Terazawa,Jin Matsuyama,Masahiro Goto,Ryohei Kawabata,Shunji Endo,Motohiro Imano,Shoichiro Fujita,Yusuke Akamaru,Hirokazu Taniguchi,Mitsutoshi Tatsumi,Sang-Woong Lee,Yoshitaka Kurisu,Hisato Kawakami,Yukinori Kurokawa,Toshio Shimokawa,Daisuke Sakai,Takeshi Kato,Kazumasa Fujitani,Taroh Satoh,The oncologist,Vol. 25,No. 2,2020年02月,研究論文(学術雑誌)
  • BIG BANG study (EPOC1703): multicentre, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy with binimetinib, encorafenib and cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer,Daisuke Kotani,Hideaki Bando,Hiroya Taniguchi,Toshiki Masuishi,Yoshito Komatsu,Kensei Yamaguchi,Takako Nakajima,Taroh Satoh,Tomohiro Nishina,Taito Esaki,Shogo Nomura,Koji Takahashi,Shinobu Iida,Seiko Matsuda,Shinya Motonaga,Nozomu Fuse,Akihiro Sato,Satoshi Fujii,Atsushi Ohtsu,Hiromichi Ebi,Takayuki Yoshino,ESMO Open,Elsevier BV,Vol. 5,No. 1,p. e000624-e000624,2020年,研究論文(学術雑誌)
  • Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer.,Taroh Satoh,Yoon-Koo Kang,Yee Chao,Min-Hee Ryu,Ken Kato,Hyun Cheol Chung,Jen-Shi Chen,Kei Muro,Won Ki Kang,Kun-Huei Yeh,Takaki Yoshikawa,Sang Cheul Oh,Li-Yuan Bai,Takao Tamura,Keun-Wook Lee,Yasuo Hamamoto,Jong Gwang Kim,Keisho Chin,Do-Youn Oh,Keiko Minashi,Jae Yong Cho,Masahiro Tsuda,Mitsunobu Tanimoto,Li-Tzong Chen,Narikazu Boku,Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,Vol. 23,No. 1,p. 143-153,2020年01月,研究論文(学術雑誌)
  • Dysphagia Score as a Predictor of Adverse Events Due to Triplet Chemotherapy and Oncological Outcomes in 434 Consecutive Patients with Esophageal Cancer.,Takaomi Hagi,Tomoki Makino,Makoto Yamasaki,Koji Tanaka,Naohiro Nishida,Daisuke Sakai,Masaaki Motoori,Yutaka Kimura,Taroh Satoh,Masaki Mori,Yuichiro Doki,Annals of surgical oncology,Vol. 26,No. 13,p. 4754-4764,2019年12月,研究論文(学術雑誌)
  • Combination Therapy With S-1, Oxaliplatin and Leucovorin in Patients With Advanced Esophageal Squamous Cell Carcinoma,Naohiro Nishida,Makoto Yamsaki,Kazuki Odagiri,Kotaro Yamashita,Koji Tanaka,Daisuke Sakai,Tomoki Makino,Tsuyoshi Takahashi,Yukinori Kurokawa,Taroh Satoh,Masaki Mori,Yuichiro Doki,IN VIVO,INT INST ANTICANCER RESEARCH,Vol. 33,No. 6,p. 2249-2254,2019年11月,研究論文(学術雑誌)
  • Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study.,Tsunekazu Mizushima,Masataka Ikeda,Takeshi Kato,Atsuyo Ikeda,Junichi Nishimura,Taishi Hata,Chu Matsuda,Taroh Satoh,Masaki Mori,Yuichiro Doki,BMC cancer,Vol. 19,No. 1,p. 929-929,2019年09月18日,研究論文(学術雑誌)
  • Gallbladder cancer harboring ERBB2 mutation on the primary and metastatic site: A case report.,Chiaki Inagaki,Daichi Maeda,Akie Kimura,Toru Otsuru,Yoshifumi Iwagami,Naohiro Nishida,Daisuke Sakai,Ryo Shitotsuki,Shinichi Yachida,Yuichiro Doki,Taroh Satoh,World journal of gastrointestinal oncology,Vol. 11,No. 9,p. 761-767,2019年09月15日
  • Application of C. elegans cancer screening test for the detection of pancreatic tumor in genetically engineered mice.,Yuji Ueda,Koichi Kawamoto,Masamitsu Konno,Kozo Noguchi,Satoru Kaifuchi,Taroh Satoh,Hidetoshi Eguchi,Yuichiro Doki,Takaaki Hirotsu,Masaki Mori,Hideshi Ishii,Oncotarget,Vol. 10,No. 52,p. 5412-5418,2019年09月10日,研究論文(学術雑誌)
  • Distinct methylation levels of mature microRNAs in gastrointestinal cancers.,Masamitsu Konno,Jun Koseki,Ayumu Asai,Akira Yamagata,Teppei Shimamura,Daisuke Motooka,Daisuke Okuzaki,Koichi Kawamoto,Tsunekazu Mizushima,Hidetoshi Eguchi,Shuji Takiguchi,Taroh Satoh,Koshi Mimori,Takahiro Ochiya,Yuichiro Doki,Ken Ofusa,Masaki Mori,Hideshi Ishii,Nature communications,Vol. 10,No. 1,p. 3888-3888,2019年08月29日,研究論文(学術雑誌)
  • Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumors.,Kohei Shitara,Taroh Satoh,Satoru Iwasa,Kensei Yamaguchi,Kei Muro,Yoshito Komatsu,Tomohiro Nishina,Taito Esaki,Jun Hasegawa,Yasuyuki Kakurai,Emi Kamiyama,Tomoko Nakata,Kota Nakamura,Hayato Sakaki,Ichinosuke Hyodo,Journal for immunotherapy of cancer,Vol. 7,No. 1,p. 219-219,2019年08月14日,研究論文(学術雑誌)
  • A Hydrogen Peroxide Activatable Gemcitabine Prodrug for the Selective Treatment of Pancreatic Ductal Adenocarcinoma.,Katsunori Matsushita,Takumi Okuda,Shohei Mori,Masamitsu Konno,Hidetoshi Eguchi,Ayumu Asai,Jun Koseki,Yoshifumi Iwagami,Daisaku Yamada,Hirofumi Akita,Tadafumi Asaoka,Takehiro Noda,Koichi Kawamoto,Kunihito Gotoh,Shogo Kobayashi,Yuuya Kasahara,Kunihiko Morihiro,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Satoshi Obika,ChemMedChem,Vol. 14,No. 15,p. 1384-1391,2019年08月06日,研究論文(学術雑誌)
  • Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial.,Toshihiko Doi,Satoru Iwasa,Kei Muro,Taroh Satoh,Shuichi Hironaka,Taito Esaki,Tomohiro Nishina,Hiroki Hara,Nozomu Machida,Yoshito Komatsu,Yasuhiro Shimada,Satoshi Otsu,Shin Shimizu,Morihiro Watanabe,Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,Vol. 22,No. 4,p. 817-827,2019年07月,研究論文(学術雑誌)
  • Large-Scale, Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real-World Clinical Setting.,Kensei Yamaguchi,Yoshito Komatsu,Taroh Satoh,Hiroyuki Uetake,Takayuki Yoshino,Toshirou Nishida,Naoya Yamazaki,Hajime Takikawa,Takashi Morimoto,Masayuki Chosa,Toshiyuki Sunaya,Yoko Hamada,Kei Muro,Kenichi Sugihara,The oncologist,Vol. 24,No. 7,2019年07月,研究論文(学術雑誌)
  • First-line single-agent panitumumab in frail elderly patients with wild-type RAS unresectable colorectal cancer: a phase II study protocol OGSG 1602.,Tetsuji Terazawa,Takeshi Kato,Masahiro Goto,Daisuke Sakai,Yukinori Kurokawa,Toshio Shimokawa,Yoshihiro Matsubara,Taroh Satoh,BMC cancer,Vol. 19,No. 1,p. 623-623,2019年06月25日,研究論文(学術雑誌)
  • 大腸癌における新規転移規定因子の同定,西田 尚弘,石川 慧,鉾之原 健太郎,坂井 大介,三吉 範克,高橋 秀和,原口 直紹,畑 泰司,松田 宙,水島 恒和,佐藤 太郎,土岐 祐一郎,森 正樹,日本外科学会定期学術集会抄録集,(一社)日本外科学会,Vol. 119回,p. SF-7,2019年04月
  • セツキシマブ耐性大腸癌における化学療法感受性とmicroRNAの関連性,波多 豪,工藤 敏啓,今野 雅允,坂井 大介,西田 尚弘,三吉 範克,高橋 秀和,原口 直紹,西村 潤一,畑 泰司,松田 宙,水島 恒和,山本 浩文,石井 秀始,土岐 祐一郎,森 正樹,佐藤 太郎,日本外科学会定期学術集会抄録集,(一社)日本外科学会,Vol. 119回,p. PS-3,2019年04月
  • Mitochondrial pyruvate carrier 1 expression controls cancer epithelial-mesenchymal transition and radioresistance.,Yuji Takaoka,Masamitsu Konno,Jun Koseki,Hugh Colvin,Ayumu Asai,Keisuke Tamari,Taroh Satoh,Masaki Mori,Yuichiro Doki,Kazuhiko Ogawa,Hideshi Ishii,Cancer science,Vol. 110,No. 4,p. 1331-1339,2019年04月,研究論文(学術雑誌)
  • A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2).,Ken Kato,Taroh Satoh,Kei Muro,Takaki Yoshikawa,Takao Tamura,Yasuo Hamamoto,Keisho Chin,Keiko Minashi,Masahiro Tsuda,Kensei Yamaguchi,Nozomu Machida,Taito Esaki,Masahiro Goto,Yoshito Komatsu,Takako Eguchi Nakajima,Naotoshi Sugimoto,Kazuhiro Yoshida,Eiji Oki,Tomohiro Nishina,Akihito Tsuji,Hirofumi Fujii,Kenji Kunieda,Soh Saitoh,Yasushi Omuro,Mizutomo Azuma,Yasuo Iwamoto,Keisei Taku,Sachio Fushida,Li-Tzong Chen,Yoon-Koo Kang,Narikazu Boku,Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,Vol. 22,No. 2,p. 344-354,2019年03月,研究論文(学術雑誌)
  • Trastuzumab With S-1 Plus Cisplatin in HER2-positive Advanced Gastric Cancer Without Measurable Lesions: OGSG 1202.,Shunji Endo,Yukinori Kurokawa,Makio Gamoh,Yutaka Kimura,Jin Matsuyama,Hirokazu Taniguchi,Atsushi Takeno,Ryohei Kawabata,Junji Kawada,Toru Masuzawa,Kazuyoshi Yamamoto,Kouji Kobayashi,Daisuke Sakai,Toshio Shimokawa,Taroh Satoh,Anticancer research,Vol. 39,No. 2,p. 1059-1065,2019年02月,研究論文(学術雑誌)
  • Nivolumab-induced interstitial lung disease in a patient with gastric cancer.,Akie Kimura,Daisuke Sakai,Toshihiro Kudo,Naohiro Nishida,Aya Katou,Chiaki Inagaki,Toru Otsuru,Yasuhiro Miyazaki,Koji Tanaka,Tomoki Makino,Tsuyoshi Takahashi,Yukinori Kurokawa,Makoto Yamasaki,Masaki Mori,Yuichiro Doki,Taroh Satoh,Oxford medical case reports,Vol. 2019,No. 2,2019年02月
  • Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells.,Reishi Toshiyama,Masamitsu Konno,Hidetoshi Eguchi,Hiroyasu Takemoto,Takehiro Noda,Ayumu Asai,Jun Koseki,Naotsugu Haraguchi,Yuji Ueda,Katsunori Matsushita,Kei Asukai,Tomofumi Ohashi,Yoshifumi Iwagami,Daisaku Yamada,Daisuke Sakai,Tadafumi Asaoka,Toshihiro Kudo,Koichi Kawamoto,Kunihito Gotoh,Shogo Kobayashi,Taroh Satoh,Yuichiro Doki,Nobuhiro Nishiyama,Masaki Mori,Hideshi Ishii,Oncogene,Vol. 38,No. 2,p. 244-260,2019年01月,研究論文(学術雑誌)
  • A Phase I Study of Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI) in Patients with Locally Advanced Rectal Cancer.,Toshihiro Kudo,Ichiro Takemasa,Tsuyoshi Hata,Daisuke Sakai,Hidekazu Takahashi,Naotsugu Haraguchi,Junichi Nishimura,Taishi Hata,Chu Matsuda,Taroh Satoh,Tsunekazu Mizushima,Masaki Mori,Yuichiro Doki,Oncology,Vol. 97,No. 4,p. 211-216,2019年,研究論文(学術雑誌)
  • Rationale and design of the BRAVERY study (EPOC1701): a multicentre phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancer.,Toshiki Masuishi,Hiroya Taniguchi,Daisuke Kotani,Hideaki Bando,Yoshito Komatsu,Eiji Shinozaki,Takako Eguchi Nakajima,Taroh Satoh,Tomohiro Nishina,Taito Esaki,Masashi Wakabayashi,Shogo Nomura,Koji Takahashi,Hiromi Ono,Nami Hirano,Noriko Fujishiro,Nozomu Fuse,Akihiro Sato,Atsushi Ohtsu,Takayuki Yoshino,ESMO open,Vol. 4,No. 6,2019年,研究論文(学術雑誌)
  • Randomized, Open-Label Phase II Study Comparing Capecitabine-Cisplatin Every 3 Weeks with S-1-Cisplatin Every 5 Weeks in Chemotherapy-Naïve Patients with HER2-Negative Advanced Gastric Cancer: OGSG1105, HERBIS-4A Trial.,Hisato Kawakami,Atsushi Takeno,Shunji Endo,Yoichi Makari,Junji Kawada,Hirokazu Taniguchi,Shigeyuki Tamura,Naotoshi Sugimoto,Yutaka Kimura,Takao Tamura,Kazumasa Fujitani,Daisuke Sakai,Toshio Shimokawa,Yukinori Kurokawa,Taroh Satoh,The oncologist,Vol. 23,No. 12,2018年12月,研究論文(学術雑誌)
  • A Convolutional Neural Network Uses Microscopic Images to Differentiate between Mouse and Human Cell Lines and Their Radioresistant Clones.,Masayasu Toratani,Masamitsu Konno,Ayumu Asai,Jun Koseki,Koichi Kawamoto,Keisuke Tamari,Zhihao Li,Daisuke Sakai,Toshihiro Kudo,Taroh Satoh,Katsutoshi Sato,Daisuke Motooka,Daisuke Okuzaki,Yuichiro Doki,Masaki Mori,Kazuhiko Ogawa,Hideshi Ishii,Cancer research,Vol. 78,No. 23,p. 6703-6707,2018年12月01日,研究論文(学術雑誌)
  • Phase 1 study of olaratumab plus doxorubicin in Japanese patients with advanced soft-tissue sarcoma.,Kan Yonemori,Makoto Kodaira,Taroh Satoh,Toshihiro Kudo,Shunji Takahashi,Kenji Nakano,Yuichi Ando,Tomoya Shimokata,Joji Mori,Koichi Inoue,Gerard J Oakley,Sachi Sakaguchi,Kenji Tamura,Cancer science,Vol. 109,No. 12,p. 3962-3970,2018年12月,研究論文(学術雑誌)
  • Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study.,Hiroya Taniguchi,Wataru Okamoto,Kei Muro,Kiwamu Akagi,Hiroki Hara,Tomohiro Nishina,Takeshi Kajiwara,Tadamichi Denda,Shuichi Hironaka,Toshihiro Kudo,Taroh Satoh,Takeharu Yamanaka,Yukiko Abe,Yoshiyuki Fukushima,Takayuki Yoshino,Neoplasia (New York, N.Y.),Vol. 20,No. 12,p. 1219-1226,2018年12月,研究論文(学術雑誌)
  • Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2.,Ayumu Asai,Jun Koseki,Masamitsu Konno,Tatsunori Nishimura,Noriko Gotoh,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Heliyon,Vol. 4,No. 12,2018年12月,研究論文(学術雑誌)
  • Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study.,Kensei Yamaguchi,Kazumasa Fujitani,Fumio Nagashima,Yasushi Omuro,Nozomu Machida,Tomohiro Nishina,Toshiko Koue,Mika Tsujimoto,Kaijiro Maeda,Taroh Satoh,Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,Vol. 21,No. 6,p. 1041-1049,2018年11月,研究論文(学術雑誌)
  • Increased Tim-3+ T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients.,Ryo Kato,Makoto Yamasaki,Shinya Urakawa,Kentaro Nishida,Tomoki Makino,Akiko Morimoto-Okazawa,Atsunari Kawashima,Kota Iwahori,Susumu Suzuki,Ryuzo Ueda,Masaki Mori,Taroh Satoh,Yuichiro Doki,Hisashi Wada,Cancer immunology, immunotherapy : CII,Vol. 67,No. 11,p. 1673-1683,2018年11月,研究論文(学術雑誌)
  • 癌幹細胞の代謝とエピジェネティクスの関係を標的とした創薬(Elucidation of a linkage of cancer metabolism and epigenetic control in cancer stem cells for drug discovery),玉利 慶介,今野 雅允,小関 準,浅井 歩,佐藤 太郎,土岐 祐一郎,森 正樹,小川 和彦,石井 秀始,日本癌学会総会記事,(一社)日本癌学会,Vol. 77回,p. 918-918,2018年09月
  • Cell-free culture conditioned medium elicits pancreatic β cell lineage-specific epigenetic reprogramming in mice.,Koichi Kawamoto,Tomofumi Ohashi,Masamitsu Konno,Naohiro Nishida,Jun Koseki,Hidetoshi Matsui,Daisuke Sakai,Toshihiro Kudo,Hidetoshi Eguchi,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Oncology letters,Vol. 16,No. 3,p. 3255-3259,2018年09月,研究論文(学術雑誌)
  • The mitochondrial one-carbon metabolic pathway is associated with patient survival in pancreatic cancer.,Kozo Noguchi,Masamitsu Konno,Jun Koseki,Naohiro Nishida,Koichi Kawamoto,Daisaku Yamada,Tadafumi Asaoka,Takehiro Noda,Hiroshi Wada,Kunihito Gotoh,Daisuke Sakai,Toshihiro Kudo,Taroh Satoh,Hidetoshi Eguchi,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Oncology letters,Vol. 16,No. 2,p. 1827-1834,2018年08月,研究論文(学術雑誌)
  • c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer.,Kozo Noguchi,Masamitsu Konno,Hidetoshi Eguchi,Koichi Kawamoto,Ryouta Mukai,Naohiro Nishida,Jun Koseki,Hiroshi Wada,Hirofumi Akita,Taroh Satoh,Shigeru Marubashi,Hiroaki Nagano,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Oncology letters,Vol. 16,No. 2,p. 1892-1898,2018年08月,研究論文(学術雑誌)
  • Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.,Charles S Fuchs,Toshihiko Doi,Raymond W Jang,Kei Muro,Taroh Satoh,Manuela Machado,Weijing Sun,Shadia I Jalal,Manish A Shah,Jean-Phillipe Metges,Marcelo Garrido,Talia Golan,Mario Mandala,Zev A Wainberg,Daniel V Catenacci,Atsushi Ohtsu,Kohei Shitara,Ravit Geva,Jonathan Bleeker,Andrew H Ko,Geoffrey Ku,Philip Philip,Peter C Enzinger,Yung-Jue Bang,Diane Levitan,Jiangdian Wang,Minori Rosales,Rita P Dalal,Harry H Yoon,JAMA oncology,Vol. 4,No. 5,2018年05月10日,研究論文(学術雑誌)
  • Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm.,Akira Sawaki,Yasuhide Yamada,Kensei Yamaguchi,Tomohiro Nishina,Toshihiko Doi,Taroh Satoh,Keisho Chin,Narikazu Boku,Yasushi Omuro,Yoshito Komatsu,Yasuo Hamamoto,Wasaburo Koizumi,Shigehira Saji,Manish A Shah,Eric Van Cutsem,Yoon-Koo Kang,Junko Iwasaki,Hiroshi Kuriki,Wataru Ohtsuka,Atsushi Ohtsu,Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,Vol. 21,No. 3,p. 429-438,2018年05月,研究論文(学術雑誌)
  • Association of iron metabolic enzyme hepcidin expression levels with the prognosis of patients with pancreatic cancer.,Reishi Toshiyama,Masamitsu Konno,Hidetoshi Eguchi,Ayumu Asai,Takehiro Noda,Jun Koseki,Kei Asukai,Tomofumi Ohashi,Katsunori Matsushita,Yoshifumi Iwagami,Daisaku Yamada,Tadafumi Asaoka,Hiroshi Wada,Koichi Kawamoto,Kunihito Gotoh,Toshihiro Kudo,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Oncology letters,Vol. 15,No. 5,p. 8125-8133,2018年05月,研究論文(学術雑誌)
  • Fetal hepatocyte-derived culture medium elicits adipocyte differentiation to bile duct cell lineages in a mouse model.,Hisataka Ogawa,Masamitsu Konno,Koichi Kawamoto,Naohiro Nishida,Jun Koseki,Tsunekazu Mizushima,Taroh Satoh,Hidetoshi Eguchi,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Biomedical reports,Vol. 8,No. 5,p. 497-499,2018年05月,研究論文(学術雑誌)
  • Mitochondrial pyruvate carrier modulates the epithelial-mesenchymal transition in cholangiocarcinoma.,Tomofumi Ohashi,Hidetoshi Eguchi,Koichi Kawamoto,Masamitsu Konno,Ayumu Asai,Hugh Colvin,Yuji Ueda,Hirofumi Takaoka,Yoshifumi Iwagami,Daisaku Yamada,Tadafumi Asaoka,Takehiro Noda,Hiroshi Wada,Kunihito Gotoh,Shogo Kobayashi,Jun Koseki,Taroh Satoh,Kazuhiko Ogawa,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Oncology reports,Vol. 39,No. 3,p. 1276-1282,2018年03月,研究論文(学術雑誌)
  • The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells.,Kosuke Taketo,Masamitsu Konno,Ayumu Asai,Jun Koseki,Masayasu Toratani,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Kazuhiko Ogawa,International journal of oncology,Vol. 52,No. 2,p. 621-629,2018年02月,研究論文(学術雑誌)
  • Hypoxia stimulates the cytoplasmic localization of oncogenic long noncoding RNA LINC00152 in colorectal cancer.,Yujiro Nishizawa,Masamitsu Konno,Ayumu Asai,Jun Koseki,Koichi Kawamoto,Norikatsu Miyoshi,Hidekazu Takahashi,Naohiro Nishida,Naotsugu Haraguchi,Daisuke Sakai,Toshihiro Kudo,Taishi Hata,Chu Matsuda,Tsunekazu Mizushima,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,International journal of oncology,Vol. 52,No. 2,p. 453-460,2018年02月,研究論文(学術雑誌)
  • Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer.,Yujiro Nishizawa,Masamitsu Konno,Ayumu Asai,Jun Koseki,Koichi Kawamoto,Norikatsu Miyoshi,Hidekazu Takahashi,Naohiro Nishida,Naotsugu Haraguchi,Daisuke Sakai,Toshihiro Kudo,Taishi Hata,Chu Matsuda,Tsunekazu Mizushima,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Oncotarget,Vol. 9,No. 7,p. 7476-7486,2018年01月26日,研究論文(学術雑誌)
  • Computational trans-omics approach characterised methylomic and transcriptomic involvements and identified novel therapeutic targets for chemoresistance in gastrointestinal cancer stem cells.,Masamitsu Konno,Hidetoshi Matsui,Jun Koseki,Ayumu Asai,Yoshihiro Kano,Koichi Kawamoto,Naohiro Nishida,Daisuke Sakai,Toshihiro Kudo,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Scientific reports,Vol. 8,No. 1,p. 899-899,2018年01月17日,研究論文(学術雑誌)
  • Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysis.,Jun Koseki,Masamitsu Konno,Ayumu Asai,Hugh Colvin,Koichi Kawamoto,Naohiro Nishida,Daisuke Sakai,Toshihiro Kudo,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Scientific reports,Vol. 8,No. 1,p. 303-303,2018年01月10日,研究論文(学術雑誌)
  • Prolonged Neoadjuvant Therapy for Locally Advanced Pancreatic Cancer.,Hidetoshi Eguchi,Daisaku Yamada,Yoshifumi Iwagami,Kunihito Gotoh,Koichi Kawamoto,Hiroshi Wada,Tadafumi Asaoka,Takehiro Noda,Yutaka Takeda,Masahiro Tanemura,Daisuke Sakai,Taroh Satoh,Toshihiro Kudo,Fumiaki Isohashi,Masaki Mori,Yuichiro Doki,Digestive surgery,Vol. 35,No. 1,p. 70-76,2018年,研究論文(学術雑誌)
  • Polyamine flux suppresses histone lysine demethylases and enhances ID1 expression in cancer stem cells.,Keisuke Tamari,Masamitsu Konno,Ayumu Asai,Jun Koseki,Kazuhiko Hayashi,Koichi Kawamoto,Noriyuki Murai,Senya Matsufuji,Fumiaki Isohashi,Taroh Satoh,Noriko Goto,Shinji Tanaka,Yuichiro Doki,Masaki Mori,Kazuhiko Ogawa,Hideshi Ishii,Cell death discovery,Vol. 4,p. 104-104,2018年,研究論文(学術雑誌)
  • A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis.,Shinya Urakawa,Daisuke Sakai,Yasuhiro Miyazaki,Toshihiro Kudo,Aya Katou,Chiaki Inagaki,Koji Tanaka,Tomoki Makino,Tsuyoshi Takahashi,Yukinori Kurokawa,Makoto Yamasaki,Kiyokazu Nakajima,Shuji Takiguchi,Taroh Satoh,Masaki Mori,Yuichiro Doki,Surgical case reports,Vol. 3,No. 1,p. 127-127,2017年12月19日,研究論文(学術雑誌)
  • Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial.,Yoon-Koo Kang,Narikazu Boku,Taroh Satoh,Min-Hee Ryu,Yee Chao,Ken Kato,Hyun Cheol Chung,Jen-Shi Chen,Kei Muro,Won Ki Kang,Kun-Huei Yeh,Takaki Yoshikawa,Sang Cheul Oh,Li-Yuan Bai,Takao Tamura,Keun-Wook Lee,Yasuo Hamamoto,Jong Gwang Kim,Keisho Chin,Do-Youn Oh,Keiko Minashi,Jae Yong Cho,Masahiro Tsuda,Li-Tzong Chen,Lancet (London, England),Vol. 390,No. 10111,p. 2461-2471,2017年12月02日,研究論文(学術雑誌)
  • Neoadjuvant CapeOx therapy followed by sphincter-preserving surgery for lower rectal cancer.,Taishi Hata,Hidekazu Takahashi,Daisuke Sakai,Naotsugu Haraguchi,Junichi Nishimura,Toshihiro Kudo,Matsuda Chu,Ichiro Takemasa,Satoh Taroh,Tsunekazu Mizushima,Yuichiro Doki,Masaki Mori,Surgery today,Vol. 47,No. 11,p. 1372-1377,2017年11月,研究論文(学術雑誌)
  • Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer.,Kohei Shitara,Tae Min Kim,Tomoya Yokota,Masahiro Goto,Taroh Satoh,Jin-Hee Ahn,Hyo Song Kim,Sylvie Assadourian,Corinne Gomez,Marzia Harnois,Satoshi Hamauchi,Toshihiro Kudo,Toshihido Doi,Yung-Jue Bang,Oncotarget,Vol. 8,No. 45,p. 79546-79555,2017年10月03日,研究論文(学術雑誌)
  • Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma.,Kei Asukai,Koichi Kawamoto,Hidetoshi Eguchi,Masamitsu Konno,Ayumu Asai,Yoshifumi Iwagami,Daisaku Yamada,Tadafumi Asaoka,Takehiro Noda,Hiroshi Wada,Kunihito Gotoh,Naohiro Nishida,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Annals of surgical oncology,Vol. 24,No. 8,p. 2344-2352,2017年08月,研究論文(学術雑誌)
  • Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial.,Toshihiro Kudo,Yasuo Hamamoto,Ken Kato,Takashi Ura,Takashi Kojima,Takahiro Tsushima,Shuichi Hironaka,Hiroki Hara,Taroh Satoh,Satoru Iwasa,Kei Muro,Hirofumi Yasui,Keiko Minashi,Kensei Yamaguchi,Atsushi Ohtsu,Yuichiro Doki,Yuko Kitagawa,The Lancet. Oncology,Vol. 18,No. 5,p. 631-639,2017年05月,研究論文(学術雑誌)
  • The one-carbon metabolism pathway highlights therapeutic targets for gastrointestinal cancer (Review).,Masamitsu Konno,Ayumu Asai,Koichi Kawamoto,Naohiro Nishida,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,International journal of oncology,Vol. 50,No. 4,p. 1057-1063,2017年04月,研究論文(学術雑誌)
  • Clinical Significance of Histone Demethylase NO66 in Invasive Colorectal Cancer.,Yujiro Nishizawa,Naohiro Nishida,Masamitsu Konno,Koichi Kawamoto,Ayumu Asai,Jun Koseki,Hidekazu Takahashi,Naotsugu Haraguchi,Junichi Nishimura,Taishi Hata,Chu Matsuda,Tsunekazu Mizushima,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Annals of surgical oncology,Vol. 24,No. 3,p. 841-849,2017年03月,研究論文(学術雑誌)
  • Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea.,Hiroyoshi Takemoto,Junichi Nishimura,Takamichi Komori,Ho Min Kim,Hirofumi Ota,Rei Suzuki,Masakazu Ikenaga,Masataka Ikeda,Hirofumi Yamamoto,Taroh Satoh,Taishi Hata,Ichiro Takemasa,Tsunekazu Mizushima,Yuichirou Doki,Masaki Mori,International journal of clinical oncology,Vol. 22,No. 1,p. 88-95,2017年02月,研究論文(学術雑誌)
  • S-1 and oxaliplatin (SOX) plus bevacizumab versus mFOLFOX6 plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: updated overall survival analyses of the open-label, non-inferiority, randomised phase III: SOFT study.,Hideo Baba,Yasuhide Yamada,Daisuke Takahari,Hiroshi Matsumoto,Kazuhiro Yoshida,Masato Nakamura,Motoki Yoshida,Shigeyoshi Iwamoto,Ken Shimada,Yoshito Komatsu,Yasutsuna Sasaki,Taroh Satoh,Keiichi Takahashi,Hideyuki Mishima,Kei Muro,Masahiko Watanabe,Yuh Sakata,Satoshi Morita,Yasuhiro Shimada,Kenichi Sugihara,ESMO open,Vol. 2,No. 1,2017年,研究論文(学術雑誌)
  • Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab.,Masahito Kotaka,Ruihua Xu,Kei Muro,Young Suk Park,Satoshi Morita,Satoru Iwasa,Hiroyuki Uetake,Tomohiro Nishina,Hiroaki Nozawa,Hiroshi Matsumoto,Kentaro Yamazaki,Sae-Won Han,Wei Wang,Joong Bae Ahn,Yanhong Deng,Sang-Hee Cho,Yi Ba,Keun-Wook Lee,Tao Zhang,Taroh Satoh,Marc E Buyse,Baek-Yeol Ryoo,Lin Shen,Junichi Sakamoto,Tae Won Kim,Chinese journal of cancer,Vol. 35,No. 1,p. 102-102,2016年12月22日,研究論文(学術雑誌)
  • Metabolic Adaptation to Nutritional Stress in Human Colorectal Cancer.,Masaaki Miyo,Masamitsu Konno,Naohiro Nishida,Toshinori Sueda,Kozo Noguchi,Hidetoshi Matsui,Hugh Colvin,Koichi Kawamoto,Jun Koseki,Naotsugu Haraguchi,Junichi Nishimura,Taishi Hata,Noriko Gotoh,Fumio Matsuda,Taroh Satoh,Tsunekazu Mizushima,Hiroshi Shimizu,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Scientific reports,Vol. 6,p. 38415-38415,2016年12月07日,研究論文(学術雑誌)
  • Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal Cancer.,Hugh Colvin,Naohiro Nishida,Masamitsu Konno,Naotsugu Haraguchi,Hidekazu Takahashi,Junichi Nishimura,Taishi Hata,Koichi Kawamoto,Ayumu Asai,Kenta Tsunekuni,Jun Koseki,Tsunekazu Mizushima,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Scientific reports,Vol. 6,p. 36289-36289,2016年11月08日,研究論文(学術雑誌)
  • MicroRNA miR-374, a potential radiosensitizer for carbon ion beam radiotherapy.,Sung-Jae Baek,Katsutoshi Sato,Naohiro Nishida,Jun Koseki,Rikako Azuma,Koichi Kawamoto,Masamitsu Konno,Kazuhiko Hayashi,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Kazuhiko Ogawa,Oncology reports,Vol. 36,No. 5,p. 2946-2950,2016年11月,研究論文(学術雑誌)
  • [Recurrence of Jejunal Carcinoma in the Ileum and Ovary - A Case Report].,Nobuyoshi Ohara,Naotsugu Haraguchi,Toshihiro Kudo,Hidekazu Takahashi,Junichi Nishimura,Taishi Hata,Chu Matsuda,Taroh Satoh,Tsunekazu Mizushima,Hirofumi Yamamoto,Yuichiro Doki,Masaki Mori,Gan to kagaku ryoho. Cancer & chemotherapy,Vol. 43,No. 12,p. 1803-1805,2016年11月,研究論文(学術雑誌)
  • Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer.,Tsuyoshi Hata,Toshihiro Kudo,Daisuke Sakai,Hidekazu Takahashi,Naotsugu Haraguchi,Junichi Nishimura,Taishi Hata,Tsunekazu Mizushima,Hirofumi Yamamoto,Yuichiro Doki,Masaki Mori,Taroh Satoh,Cancer chemotherapy and pharmacology,Vol. 78,No. 2,p. 389-96,2016年08月,研究論文(学術雑誌)
  • First-line cetuximab-based chemotherapies for patients with advanced or metastatic KRAS wild-type colorectal cancer.,Mamoru Uemura,Ho Min Kim,Tsuyoshi Hata,Kazuya Sakata,Masaki Okuyama,Hiroyoshi Takemoto,Hitoshi Fujii,Takayuki Fukuzaki,Tetsushi Morita,Taishi Hata,Ichiro Takemasa,Taroh Satoh,Tsunekazu Mizushima,Yuichiro Doki,Maski Mori,Molecular and clinical oncology,Vol. 5,No. 2,p. 375-379,2016年08月,研究論文(学術雑誌)
  • Efficacy and Safety of Regorafenib or TAS-102 in Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies.,Toshinori Sueda,Daisuke Sakai,Toshihiro Kudo,Takashi Sugiura,Hidekazu Takahashi,Naotsugu Haraguchi,Junichi Nishimura,Taishi Hata,Taro Hayashi,Tsunekazu Mizushima,Yuichiro Doki,Masaki Mori,Taroh Satoh,Anticancer research,Vol. 36,No. 8,p. 4299-306,2016年08月,研究論文(学術雑誌)
  • HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer.,Naoki Takegawa,Kimio Yonesaka,Kazuko Sakai,Hiroto Ueda,Satomi Watanabe,Yoshikane Nonagase,Tatsuya Okuno,Masayuki Takeda,Osamu Maenishi,Junji Tsurutani,Taroh Satoh,Isamu Okamoto,Kazuto Nishio,Takao Tamura,Kazuhiko Nakagawa,Oncotarget,Vol. 7,No. 3,p. 3453-60,2016年01月19日,研究論文(学術雑誌)
  • BRAF V600E inhibition stimulates AMP-activated protein kinase-mediated autophagy in colorectal cancer cells.,Toshinori Sueda,Daisuke Sakai,Koichi Kawamoto,Masamitsu Konno,Naohiro Nishida,Jun Koseki,Hugh Colvin,Hidekazu Takahashi,Naotsugu Haraguchi,Junichi Nishimura,Taishi Hata,Ichiro Takemasa,Tsunekazu Mizushima,Hirofumi Yamamoto,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Scientific reports,Vol. 6,p. 18949-18949,2016年01月11日,研究論文(学術雑誌)
  • Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer.,Taroh Satoh,Kyung Hee Lee,Sun Young Rha,Yasutsuna Sasaki,Se Hoon Park,Yoshito Komatsu,Hirofumi Yasui,Tae-You Kim,Kensei Yamaguchi,Nozomu Fuse,Yasuhide Yamada,Takashi Ura,Si-Young Kim,Masaki Munakata,Soh Saitoh,Kazuto Nishio,Satoshi Morita,Eriko Yamamoto,Qingwei Zhang,Jung-mi Kim,Yeul Hong Kim,Yuh Sakata,Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,Vol. 18,No. 4,p. 824-32,2015年10月,研究論文(学術雑誌)
  • Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): a multicentre, randomised, controlled phase 3 trial.,Junichi Nishimura,Taroh Satoh,Mutsumi Fukunaga,Hiroyoshi Takemoto,Ken Nakata,Yoshihito Ide,Takayuki Fukuzaki,Toshihiro Kudo,Yasuhiro Miyake,Masayoshi Yasui,Shunji Morita,Daisuke Sakai,Mamoru Uemura,Taishi Hata,Ichiro Takemasa,Tsunekazu Mizushima,Yuko Ohno,Hirofumi Yamamoto,Mitsugu Sekimoto,Riichiro Nezu,Yuichiro Doki,Masaki Mori,European journal of cancer (Oxford, England : 1990),Vol. 51,No. 10,p. 1274-82,2015年07月,研究論文(学術雑誌)
  • Randomized phase II study of S-1 dosing schedule for resected colorectal cancer.,Chu Matsuda,Mamoru Uemura,Ken Nakata,Tatsushi Shingai,Junichi Nishimura,Taishi Hata,Masakazu Ikenaga,Ichiro Takemasa,Tsunekazu Mizushima,Takeshi Kato,Masataka Ikeda,Masayuki Ohue,Kohei Murata,Junichi Hasegawa,Taroh Satoh,Hirofumi Yamamoto,Mitsugu Sekimoto,Riichiro Nezu,Yuichiro Doki,Masaki Mori,BMC cancer,Vol. 15,p. 452-452,2015年06月03日,研究論文(学術雑誌)
  • A phase ib study of safety and pharmacokinetics of ramucirumab in combination with paclitaxel in patients with advanced gastric adenocarcinomas.,Shinya Ueda,Taroh Satoh,Masahiro Gotoh,Ling Gao,Toshihiko Doi,The oncologist,Vol. 20,No. 5,p. 493-4,2015年05月,研究論文(学術雑誌)
  • Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26.,Shimpei Nishikawa,Masamitsu Konno,Atsushi Hamabe,Shinichiro Hasegawa,Yoshihiro Kano,Takahito Fukusumi,Taroh Satoh,Shuji Takiguchi,Masaki Mori,Yuichiro Doki,Hideshi Ishii,Oncology letters,Vol. 9,No. 5,p. 2361-2367,2015年05月,研究論文(学術雑誌)
  • Feasibility of pre-operative chemoradiotherapy with gemcitabine to treat pancreatic cancer in patients with impaired renal function.,Yoshito Tomimaru,Hidetoshi Eguchi,Taroh Satoh,Akira Tomokuni,Tadafumi Asaoka,Hiroshi Wada,Shigeru Marubashi,Kazuhiko Ogawa,Tetsuo Takehara,Masaki Mori,Yuichiro Doki,Hiroaki Nagano,Japanese journal of clinical oncology,Vol. 45,No. 4,p. 343-8,2015年04月,研究論文(学術雑誌)
  • Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study.,Takayuki Yoshino,Kei Muro,Kensei Yamaguchi,Tomohiro Nishina,Tadamichi Denda,Toshihiro Kudo,Wataru Okamoto,Hiroya Taniguchi,Kiwamu Akagi,Takeshi Kajiwara,Shuichi Hironaka,Taroh Satoh,EBioMedicine,Vol. 2,No. 4,p. 317-23,2015年04月,研究論文(学術雑誌)
  • Circulating hepatocyte growth factor is correlated with resistance to cetuximab in metastatic colorectal cancer.,Kimio Yonesaka,Taroh Satoh,Shinya Ueda,Takeshi Yoshida,Masayuki Takeda,Toshio Shimizu,Isamu Okamoto,Kazuto Nishio,Takao Tamura,Kazuhiko Nakagawa,Anticancer research,Vol. 35,No. 3,p. 1683-9,2015年03月,研究論文(学術雑誌)
  • A phase 3 non-inferiority study of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study.,Hirofumi Yasui,Kei Muro,Yasuhiro Shimada,Akihito Tsuji,Shinichi Sameshima,Hideo Baba,Taroh Satoh,Tadamichi Denda,Kenji Ina,Tomohiro Nishina,Kensei Yamaguchi,Taito Esaki,Shinya Tokunaga,Hiroyuki Kuwano,Narikazu Boku,Yoshito Komatsu,Masahiko Watanabe,Ichinosuke Hyodo,Satoshi Morita,Kenichi Sugihara,Journal of cancer research and clinical oncology,Vol. 141,No. 1,p. 153-60,2015年01月,研究論文(学術雑誌)
  • [Chemotherapy for gastrointestinal cancer patients in elderly].,Taroh Satoh,Gan to kagaku ryoho. Cancer & chemotherapy,Vol. 42,No. 1,p. 12-5,2015年01月,研究論文(学術雑誌)
  • The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancer.,Masato Nakamura,Yasuhide Yamada,Kei Muro,Keiichi Takahashi,Hideo Baba,Yasutsuna Sasaki,Yoshito Komatsu,Taroh Satoh,Hideyuki Mishima,Masahiko Watanabe,Yuh Sakata,Satoshi Morita,Yasuhiro Shimada,Kenichi Sugihara,Future oncology (London, England),Vol. 11,No. 10,p. 1471-8,2015年,研究論文(学術雑誌)
  • Combined Analysis of Plasma Amphiregulin and Heregulin Predicts Response to Cetuximab in Metastatic Colorectal Cancer.,Kimio Yonesaka,Naoki Takegawa,Taroh Satoh,Hiroto Ueda,Takeshi Yoshida,Masayuki Takeda,Toshio Shimizu,Yasutaka Chiba,Isamu Okamoto,Kazuto Nishio,Takao Tamura,Kazuhiko Nakagawa,PloS one,Vol. 10,No. 11,2015年,研究論文(学術雑誌)
  • Safety and pharmacokinetics of S-1 in a recurrent colon cancer patient with chronic myeloid leukemia treated with dasatinib: a case report.,Toshinori Sueda,Toshihiro Kudo,Daisuke Sakai,Mamoru Uemura,Junichi Nishimura,Taishi Hata,Ichiro Takemasa,Tsunekazu Mizushima,Hirofumi Yamamoto,Sachiko Ezoe,Kana Matsumoto,Yuichiro Doki,Masaki Mori,Taroh Satoh,Cancer chemotherapy and pharmacology,Vol. 74,No. 6,p. 1321-4,2014年12月,研究論文(学術雑誌)
  • Incidence and clinical features of drug-induced lung injury in patients with advanced colorectal cancer receiving cetuximab: results of a prospective multicenter registry.,Taroh Satoh,Akihiko Gemma,Shoji Kudoh,Fumikazu Sakai,Kensei Yamaguchi,Toshiaki Watanabe,Megumi Ishiguro,Shogo Inoshiri,Makiko Izawa,Kenichi Sugihara,Yuh Sakata,Japanese journal of clinical oncology,Vol. 44,No. 11,p. 1032-9,2014年11月,研究論文(学術雑誌)
  • [First-line chemotherapy for unresectable and metastatic colorectal cancer].,Taroh Satoh,Gan to kagaku ryoho. Cancer & chemotherapy,Vol. 41,No. 11,p. 1372-5,2014年11月,研究論文(学術雑誌)
  • 慢性骨髄性白血病に対するDasatinib治療中に大腸癌再発をきたし、S-1単剤療法を安全に施行できた1例,末田 聖倫,工藤 敏啓,坂井 大介,植村 守,西村 潤一,畑 泰司,竹政 伊知朗,水島 恒和,佐藤 太郎,山本 浩文,土岐 祐一郎,森 正樹,日本大腸肛門病学会雑誌,(一社)日本大腸肛門病学会,Vol. 67,No. 9,p. 850-850,2014年09月
  • Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study.,Taroh Satoh,Rui-Hua Xu,Hyun Cheol Chung,Guo-Ping Sun,Toshihiko Doi,Jian-Ming Xu,Akihito Tsuji,Yasushi Omuro,Jin Li,Jin-Wan Wang,Hiroto Miwa,Shu-Kui Qin,Ik-Joo Chung,Kun-Huei Yeh,Ji-Feng Feng,Akihira Mukaiyama,Mikiro Kobayashi,Atsushi Ohtsu,Yung-Jue Bang,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,Vol. 32,No. 19,p. 2039-49,2014年07月01日,研究論文(学術雑誌)
  • Quality of life in the trastuzumab for gastric cancer trial.,Taroh Satoh,Yung-Jue Bang,Evgeny A Gotovkin,Yasuo Hamamoto,Yoon-Koo Kang,Vladimir M Moiseyenko,Atsushi Ohtsu,Eric Van Cutsem,Nedal Al-Sakaff,Alexa Urspruch,Julie Hill,Harald A Weber,Hyun-Cheol Chung,The oncologist,Vol. 19,No. 7,p. 712-9,2014年07月,研究論文(学術雑誌)
  • Severe infusion reactions to cetuximab occur within 1 h in patients with metastatic colorectal cancer: results of a nationwide, multicenter, prospective registry study of 2126 patients in Japan.,Kensei Yamaguchi,Toshiaki Watanabe,Taroh Satoh,Megumi Ishiguro,Makiko Izawa,Shogo Inoshiri,Kenichi Sugihara,Yuh Sakata,Japanese journal of clinical oncology,Vol. 44,No. 6,p. 541-6,2014年06月,研究論文(学術雑誌)
  • 直腸癌に対する術前CapeOx療法の安全性と効果,畑 泰司,坂井 大介,工藤 俊啓,植村 守,西村 潤一,竹政 伊知朗,水島 恒和,佐藤 太郎,山本 浩文,土岐 祐一郎,森 正樹,日本外科学会雑誌,(一社)日本外科学会,Vol. 115,No. 臨増2,p. 956-956,2014年03月
  • Novel drug discovery system for cancer stem cells in human squamous cell carcinoma of the esophagus.,Yoshihiro Kano,Masamitsu Konno,Koichi Kawamoto,Keisuke Tamari,Kazuhiko Hayashi,Takahito Fukusumi,Taroh Satoh,Shinji Tanaka,Kazuhiko Ogawa,Masaki Mori,Yuichiro Doki,Hideshi Ishii,Oncology reports,Vol. 31,No. 3,p. 1133-8,2014年03月,研究論文(学術雑誌)
  • A phase I trial of combination therapy using gemcitabine and S-1 concurrent with full-dose radiation for resectable pancreatic cancer.,Hidetoshi Eguchi,Hiroaki Nagano,Shogo Kobayashi,Koichi Kawamoto,Hiroshi Wada,Naoki Hama,Yoshito Tomimaru,Hirofumi Akita,Daisuke Sakai,Taroh Satoh,Toshihiro Kudo,Fumiaki Isohashi,Masaki Mori,Yuichiro Doki,Cancer chemotherapy and pharmacology,Vol. 73,No. 2,p. 309-15,2014年02月,研究論文(学術雑誌)
  • Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START).,Wasaburo Koizumi,Yeul Hong Kim,Masashi Fujii,Hoon Kyo Kim,Hiroshi Imamura,Kyung Hee Lee,Takuo Hara,Hyun Cheol Chung,Taroh Satoh,Jae Yong Cho,Hisashi Hosaka,Akihito Tsuji,Akinori Takagane,Mikito Inokuchi,Kazuaki Tanabe,Tatsuya Okuno,Mariko Ogura,Kazuhiro Yoshida,Masahiro Takeuchi,Toshifusa Nakajima,Journal of cancer research and clinical oncology,Vol. 140,No. 2,p. 319-28,2014年02月,研究論文(学術雑誌)
  • Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.,Yasuhide Yamada,Daisuke Takahari,Hiroshi Matsumoto,Hideo Baba,Masato Nakamura,Kazuhiro Yoshida,Motoki Yoshida,Shigeyoshi Iwamoto,Ken Shimada,Yoshito Komatsu,Yasutsuna Sasaki,Taroh Satoh,Keiichi Takahashi,Hideyuki Mishima,Kei Muro,Masahiko Watanabe,Yuh Sakata,Satoshi Morita,Yasuhiro Shimada,Kenichi Sugihara,The Lancet. Oncology,Vol. 14,No. 13,p. 1278-86,2013年12月,研究論文(学術雑誌)
  • Phase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancer.,Hidetoshi Hayashi,Isamu Okamoto,Shinya Ueda,Kaoru Tanaka,Kunio Okamoto,Hisato Kawakami,Shinichi Nishina,Masayuki Takeda,Yasuhito Fujisaka,Taroh Satoh,Kyoichi Terao,Yasumasa Nishimura,Katsumi Doi,Kazuhiko Nakagawa,Anticancer research,Vol. 33,No. 12,p. 5699-705,2013年12月,研究論文(学術雑誌)
  • Pharmacokinetic assessment of irinotecan, SN-38, and SN-38-glucuronide: a substudy of the FIRIS study.,Taroh Satoh,Hirofumi Yasui,Kei Muro,Yoshito Komatsu,Shinichi Sameshima,Kensei Yamaguchi,Kenichi Sugihara,Anticancer research,Vol. 33,No. 9,p. 3845-53,2013年09月,研究論文(学術雑誌)
  • A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1203 (HERBIS-5).,Daisuke Sakai,Taroh Satoh,Yukinori Kurokawa,Toshihiro Kudo,Kazuhiro Nishikawa,Yoshio Oka,Toshimasa Tsujinaka,Toshio Shimokawa,Yuichiro Doki,Hiroshi Furukawa,Japanese journal of clinical oncology,Vol. 43,No. 8,p. 838-40,2013年08月,研究論文(学術雑誌)
  • Jumonji/Arid1b (Jarid1b) protein modulates human esophageal cancer cell growth.,Yoshihiro Kano,Masamitsu Konno,Katsuya Ohta,Naotsugu Haraguchi,Shimpei Nishikawa,Yoshinori Kagawa,Atsushi Hamabe,Shinichiro Hasegawa,Hisataka Ogawa,Takahito Fukusumi,Yuko Noguchi,Miyuki Ozaki,Toshihiro Kudo,Daisuke Sakai,Taroh Satoh,Masaru Ishii,Eiichi Mizohata,Takeshi Inoue,Masaki Mori,Yuichiro Doki,Hideshi Ishii,Molecular and clinical oncology,Vol. 1,No. 4,p. 753-757,2013年07月,研究論文(学術雑誌)
  • Innovative cell-modifying technology targeting cancer stem cell.,Hideshi Ishii,Masamitsu Konno,Yoshinori Kagawa,Sakae Maeda,Katsuya Ohta,Yoshihiro Kano,Shimpei Nishikawa,Taroh Satoh,Yuichiro Doki,Masaki Mori,[Rinsho ketsueki] The Japanese journal of clinical hematology,Vol. 54,No. 5,p. 415-22,2013年05月,研究論文(学術雑誌)
  • Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study.,Kensei Yamaguchi,Akira Sawaki,Toshihiko Doi,Taroh Satoh,Yasuhide Yamada,Yasushi Omuro,Tomohiro Nishina,Narikazu Boku,Keisho Chin,Yasuo Hamamoto,Hiroya Takiuchi,Yoshito Komatsu,Shigehira Saji,Wasaburo Koizumi,Yoshinori Miyata,Atsushi Sato,Eishi Baba,Takao Tamura,Takashi Abe,Atsushi Ohtsu,Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,Vol. 16,No. 2,p. 175-82,2013年04月,研究論文(学術雑誌)
  • Depletion of JARID1B induces cellular senescence in human colorectal cancer.,Katsuya Ohta,Naotsugu Haraguchi,Yoshihiro Kano,Yoshinori Kagawa,Masamitsu Konno,Shimpei Nishikawa,Atsushi Hamabe,Shinichiro Hasegawa,Hisataka Ogawa,Takahito Fukusumi,Mamoru Uemura,Junichi Nishimura,Taishi Hata,Ichiro Takemasa,Tsunekazu Mizushima,Yuko Noguchi,Miyuki Ozaki,Toshihiro Kudo,Daisuke Sakai,Taroh Satoh,Miwa Fukami,Masaru Ishii,Hirofumi Yamamoto,Yuichiro Doki,Masaki Mori,Hideshi Ishii,International journal of oncology,Vol. 42,No. 4,p. 1212-8,2013年04月,研究論文(学術雑誌)
  • Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.,Shimpei Nishikawa,Masamitsu Konno,Atsushi Hamabe,Shinichiro Hasegawa,Yoshihiro Kano,Katsuya Ohta,Takahito Fukusumi,Daisuke Sakai,Toshihiro Kudo,Naotsugu Haraguchi,Taroh Satoh,Shuji Takiguchi,Masaki Mori,Yuichiro Doki,Hideshi Ishii,International journal of oncology,Vol. 42,No. 4,p. 1437-42,2013年04月,研究論文(学術雑誌)
  • A Phase I/II trial of radiotherapy concurrent with TS-1 plus cisplatin in patients with clinically resectable type 4 or large type 3 gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1205.,Motohiro Imano,Hiroshi Furukawa,Masaki Yokokawa,Yasumasa Nishimura,Yukinori Kurokawa,Taroh Satoh,Daisuke Sakai,Takushi Yasuda,Haruhiko Imamoto,Toshimasa Tujinaka,Toshio Shimokawa,Hitoshi Shiozaki,Japanese journal of clinical oncology,Vol. 43,No. 4,p. 431-5,2013年04月,研究論文(学術雑誌)
  • Adipose-derived mesenchymal stem cells and regenerative medicine.,Masamitsu Konno,Atsushi Hamabe,Shinichiro Hasegawa,Hisataka Ogawa,Takahito Fukusumi,Shimpei Nishikawa,Katsuya Ohta,Yoshihiro Kano,Miyuki Ozaki,Yuko Noguchi,Daisuke Sakai,Toshihiro Kudoh,Koichi Kawamoto,Hidetoshi Eguchi,Taroh Satoh,Masahiro Tanemura,Hiroaki Nagano,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Development, growth & differentiation,Vol. 55,No. 3,p. 309-18,2013年04月,研究論文(学術雑誌)
  • [Cancer stem cells depend on their own niche].,Yoshihiro Kano,Hideshi Ishii,Masamitsu Konno,Katsuya Ohta,Shimpei Nishikawa,Takahito Fukusumi,Atsushi Hamabe,Shinichiro Hasegawa,Hisataka Ogawa,Miyuki Ozaki,Yuko Noguchi,Daisuke Sakai,Naotsugu Haraguchi,Toshihiro Kudo,Taroh Satoh,Yuichiro Doki,Masaki Mori,Gan to kagaku ryoho. Cancer & chemotherapy,Vol. 40,No. 4,p. 419-23,2013年04月,研究論文(学術雑誌)
  • Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor.,Hidetoshi Hayashi,Takayasu Kurata,Yasuhito Fujisaka,Hisato Kawakami,Kaoru Tanaka,Takafumi Okabe,Masayuki Takeda,Taroh Satoh,Koji Yoshida,Takuya Tsunoda,Tokuzo Arao,Kazuto Nishio,Kazuhiko Nakagawa,Cancer science,Vol. 104,No. 1,p. 98-104,2013年01月,研究論文(学術雑誌)
  • Eradication of therapy-resistant cancer cells in gastrointestinal organs.,Shimpei Nishikawa,Masamitsu Konno,Atsushi Hamabe,Shinichiro Hasegawa,Hisataka Ogawa,Yoshihiro Kano,Takahito Fukusumi,Katsuya Ohta,Yuko Noguchi,Miyuki Ozaki,Toshihiro Kudo,Daisuke Sakai,Naotsugu Haraguchi,Taroh Satoh,Yuichiro Doki,Masaki Mori,Hideshi Ishii,Molecular and clinical oncology,Vol. 1,No. 1,p. 15-17,2013年01月
  • Bevacizumab in combination with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) in patients with metastatic colorectal cancer who were previously treated with oxaliplatin-containing regimens: a multicenter observational cohort study (TCTG 2nd-BV study).,Toshikazu Moriwaki,Hideaki Bando,Atsuo Takashima,Kentaro Yamazaki,Taito Esaki,Keishi Yamashita,Mutsumi Fukunaga,Yasuhiro Miyake,Kenji Katsumata,Satoshi Kato,Taroh Satoh,Mitsuharu Ozeki,Eishi Baba,Shigemasa Yoshida,Narikazu Boku,Ichinosuke Hyodo,Medical oncology (Northwood, London, England),Vol. 29,No. 4,p. 2842-8,2012年12月,研究論文(学術雑誌)
  • Clinical phase I study of elpamotide, a peptide vaccine for vascular endothelial growth factor receptor 2, in patients with advanced solid tumors.,Isamu Okamoto,Tokuzo Arao,Masaki Miyazaki,Taroh Satoh,Kunio Okamoto,Takuya Tsunoda,Kazuto Nishio,Kazuhiko Nakagawa,Cancer science,Vol. 103,No. 12,p. 2135-8,2012年12月,研究論文(学術雑誌)
  • [Esophageal cancer].,Taroh Satoh,Toshihiro Kudo,Daisuke Sakai,Naotsugu Haraguchi,Hideshi Ishii,Yuichiro Doki,Masaki Mori,Nihon rinsho. Japanese journal of clinical medicine,Vol. 70 Suppl 8,p. 434-7,2012年11月,研究論文(学術雑誌)
  • Transcriptomic study of dormant gastrointestinal cancer stem cells.,Shimpei Nishikawa,Dyah Laksmi Dewi,Hideshi Ishii,Masamitsu Konno,Naotsugu Haraguchi,Yoshihiro Kano,Takahito Fukusumi,Katsuya Ohta,Yuko Noguchi,Miyuki Ozaki,Daisuke Sakai,Taroh Satoh,Yuichiro Doki,Masaki Mori,International journal of oncology,Vol. 41,No. 3,p. 979-84,2012年09月,研究論文(学術雑誌)
  • Pharmacokinetics of sepantronium bromide (YM155), a small-molecule suppressor of survivin, in Japanese patients with advanced solid tumors: dose proportionality and influence of renal impairment.,Yumiko Aoyama,Tetsuya Nishimura,Taiji Sawamoto,Taroh Satoh,Masataka Katashima,Kazuhiko Nakagawa,Cancer chemotherapy and pharmacology,Vol. 70,No. 3,p. 373-80,2012年09月,研究論文(学術雑誌)
  • S-1 for the treatment of gastrointestinal cancer.,Taroh Satoh,Yuh Sakata,Expert opinion on pharmacotherapy,Vol. 13,No. 13,p. 1943-59,2012年09月,研究論文(学術雑誌)
  • Phase I results from a two-part Phase I/II study of cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer.,Taroh Satoh,Kensei Yamaguchi,Narikazu Boku,Wataru Okamoto,Tomotaka Shimamura,Kentaro Yamazaki,Xiaojin Shi,Hideyuki Mishima,Investigational new drugs,Vol. 30,No. 4,p. 1511-8,2012年08月,研究論文(学術雑誌)
  • Reversible posterior leukoencephalopathy syndrome and trastuzumab.,Hiroyasu Kaneda,Isamu Okamoto,Taroh Satoh,Kazuhiko Nakagawa,Investigational new drugs,Vol. 30,No. 4,p. 1766-7,2012年08月,研究論文(学術雑誌)
  • First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: a phase II study.,Yasushi Tsuji,Taroh Satoh,Akihito Tsuji,Kei Muro,Motoki Yoshida,Tomohiro Nishina,Michitaka Nagase,Yoshito Komatsu,Takeshi Kato,Yoshinori Miyata,Naoko Mizutani,Satoshi Hashigaki,Maria Jose Lechuga,Tadamichi Denda,Cancer science,Vol. 103,No. 8,p. 1502-7,2012年08月,研究論文(学術雑誌)
  • Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study.,Akira Sawaki,Yasuo Ohashi,Yasushi Omuro,Taroh Satoh,Yasuo Hamamoto,Narikazu Boku,Yoshinori Miyata,Hiroya Takiuchi,Kensei Yamaguchi,Yasutsuna Sasaki,Tomohiro Nishina,Atsushi Satoh,Eishi Baba,Takao Tamura,Takashi Abe,Kiyohiko Hatake,Atsushi Ohtsu,Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,Vol. 15,No. 3,p. 313-22,2012年07月,研究論文(学術雑誌)
  • microRNA-based cancer cell reprogramming technology.,Shimpei Nishikawa,Hideshi Ishii,Naotsugu Haraguchi,Yoshihiro Kano,Takahito Fukusumi,Katsuya Ohta,Miyuki Ozaki,Dyah Laksmi Dewi,Daisuke Sakai,Taroh Satoh,Hiroaki Nagano,Yuichiro Doki,Masaki Mori,Experimental and therapeutic medicine,Vol. 4,No. 1,p. 8-14,2012年07月,研究論文(学術雑誌)
  • Dicer 1, ribonuclease type III modulates a reprogramming effect in colorectal cancer cells.,Dyah Laksmi Dewi,Hideshi Ishii,Naotsugu Haraguchi,Shimpei Nishikawa,Yoshihiro Kano,Takahito Fukusumi,Miyuki Ozaki,Toshiyuki Saito,Daisuke Sakai,Taroh Satoh,Yuichiro Doki,Masaki Mori,International journal of molecular medicine,Vol. 29,No. 6,p. 1060-4,2012年06月,研究論文(学術雑誌)
  • Genotoxic therapy stimulates error-prone DNA repair in dormant hepatocellular cancer stem cells.,Shimpei Nishikawa,Hideshi Ishii,Naotsugu Haraguchi,Yoshihiro Kano,Takahito Fukusumi,Katsuya Ohta,Miyuki Ozaki,Daisuke Sakai,Taroh Satoh,Hiroaki Nagano,Yuichiro Doki,Masaki Mori,Experimental and therapeutic medicine,Vol. 3,No. 6,p. 959-962,2012年06月,研究論文(学術雑誌)
  • アンスラまたはタキサン耐性のHER2陽性乳癌に対するCPT-11+trastuzumab併用療法におけるfeasibility trial,西田 幸弘,富永 修盛,増田 慎三,鶴谷 純司,佐藤 太郎,川上 尚人,岡本 勇,森本 卓,山口 正秀,松並 展輝,新井 貴志,坂本 純一,中山 貴寛,中川 和彦,日本乳癌学会総会プログラム抄録集,(一社)日本乳癌学会,Vol. 20回,p. 316-316,2012年05月
  • Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.,Hiromitsu Hoshino,Hiroaki Nagano,Naotsugu Haraguchi,Shimpei Nishikawa,Akira Tomokuni,Yoshihiro Kano,Takahito Fukusumi,Toshiyuki Saito,Miyuki Ozaki,Daisuke Sakai,Taroh Satoh,Hidetoshi Eguchi,Mitsugu Sekimoto,Yuichiro Doki,Masaki Mori,Hideshi Ishii,International journal of oncology,Vol. 40,No. 5,p. 1423-30,2012年05月,研究論文(学術雑誌)
  • Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancer.,Taroh Satoh,Yasushi Omuro,Yasutsuna Sasaki,Yasuo Hamamoto,Narikazu Boku,Takao Tamura,Atsushi Ohtsu,Cancer chemotherapy and pharmacology,Vol. 69,No. 4,p. 949-55,2012年04月,研究論文(学術雑誌)
  • A Japanese post-marketing surveillance of cetuximab (Erbitux®) in patients with metastatic colorectal cancer.,Megumi Ishiguro,Toshiaki Watanabe,Kensei Yamaguchi,Taroh Satoh,Hideyuki Ito,Taku Seriu,Yuh Sakata,Kenichi Sugihara,Japanese journal of clinical oncology,Vol. 42,No. 4,p. 287-94,2012年04月,研究論文(学術雑誌)
  • Reprogramming of gastrointestinal cancer cells.,DyahLaksmi Dewi,Hideshi Ishii,Naotsugu Haraguchi,Shimpei Nishikawa,Yoshihiro Kano,Takahito Fukusumi,Katsuya Ohta,Susumu Miyazaki,Miyuki Ozaki,Daisuke Sakai,Taroh Satoh,Hiroaki Nagano,Yuichiro Doki,Masaki Mori,Cancer science,Vol. 103,No. 3,p. 393-9,2012年03月,研究論文(学術雑誌)
  • [The concept and significance of cancer stem cells].,Naotsugu Haraguchi,Hideshi ishii,Daisuke Sakai,Taroh Satoh,Yuichirou Doki,Masaki Mori,Nihon Geka Gakkai zasshi,Vol. 113,No. 2,p. 204-9,2012年03月,研究論文(学術雑誌)
  • Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer.,Taroh Satoh,Yasuhide Yamada,Kei Muro,Hidetoshi Hayashi,Yasuhiro Shimada,Daisuke Takahari,Keisei Taku,Takako Eguchi Nakajima,Xiaojin Shi,Kathryn H Brown,Narikazu Boku,Cancer chemotherapy and pharmacology,Vol. 69,No. 2,p. 439-46,2012年02月,研究論文(学術雑誌)
  • Sequential irinotecan hydrochloride/S-1 for S-1-resistant inoperable gastric cancer: A feasibility study.,Takenori Takahata,Jugoh Itoh,Taroh Satoh,Atsushi Ishiguro,Yoshifumi Matsumoto,Satoshi Tanaka,Soh Saitoh,Hiroshi Tohno,Shinsaku Fukuda,Yasuo Saijo,Yuh Sakata,Oncology letters,Vol. 3,No. 1,p. 89-93,2012年01月,研究論文(学術雑誌)
  • Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1*28 and/or UGT1A1*6 polymorphisms.,Taroh Satoh,Takashi Ura,Yasuhide Yamada,Kentaro Yamazaki,Toshimasa Tsujinaka,Masaki Munakata,Tomohiro Nishina,Shu Okamura,Taito Esaki,Yasutsuna Sasaki,Wasaburo Koizumi,Yoshihiro Kakeji,Naoki Ishizuka,Ichinosuke Hyodo,Yuh Sakata,Cancer science,Vol. 102,No. 10,p. 1868-73,2011年10月,研究論文(学術雑誌)
  • Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challenges.,Dyah Laksmi Dewi,Hideshi Ishii,Yoshihiro Kano,Shinpei Nishikawa,Naotsugu Haraguchi,Daisuke Sakai,Taroh Satoh,Yuichiro Doki,Masaki Mori,Journal of gastroenterology,Vol. 46,No. 10,p. 1145-57,2011年10月,研究論文(学術雑誌)
  • Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab.,Kimio Yonesaka,Kreshnik Zejnullahu,Isamu Okamoto,Taroh Satoh,Federico Cappuzzo,John Souglakos,Dalia Ercan,Andrew Rogers,Massimo Roncalli,Masayuki Takeda,Yasuhito Fujisaka,Juliet Philips,Toshio Shimizu,Osamu Maenishi,Yonggon Cho,Jason Sun,Annarita Destro,Koichi Taira,Koji Takeda,Takafumi Okabe,Jeffrey Swanson,Hiroyuki Itoh,Minoru Takada,Eugene Lifshits,Kiyotaka Okuno,Jeffrey A Engelman,Ramesh A Shivdasani,Kazuto Nishio,Masahiro Fukuoka,Marileila Varella-Garcia,Kazuhiko Nakagawa,Pasi A Jänne,Science translational medicine,Vol. 3,No. 99,2011年09月07日,研究論文(学術雑誌)
  • 前化学療法歴を有する切除不能・再発胆道癌に対するTS-1療法,上田 眞也,佐藤 太郎,仁科 慎一,川上 尚人,田中 薫,清田 秀美,岡本 渉,金田 裕靖,工藤 敏啓,藤阪 保仁,鶴谷 純司,宮崎 昌樹,倉田 宝保,岡本 勇,中川 和彦,日本癌治療学会誌,(一社)日本癌治療学会,Vol. 46,No. 2,p. 672-672,2011年09月
  • Human epidermal growth factor eyedrops for cetuximab-related filamentary keratitis.,Hisato Kawakami,Koji Sugioka,Kimio Yonesaka,Taroh Satoh,Yoshikazu Shimomura,Kazuhiko Nakagawa,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,Vol. 29,No. 23,2011年08月10日,研究論文(学術雑誌)
  • High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin.,Yasuhiro Kidera,Taroh Satoh,Shinya Ueda,Wataru Okamoto,Isamu Okamoto,Soichi Fumita,Kimio Yonesaka,Hidetoshi Hayashi,Chihiro Makimura,Kunio Okamoto,Hidemi Kiyota,Junji Tsurutani,Masaki Miyazaki,Masahiro Yoshinaga,Kimiko Fujiwara,Yuzuru Yamazoe,Kenzo Moriyama,Masanobu Tsubaki,Yasutaka Chiba,Shozo Nishida,Kazuhiko Nakagawa,International journal of clinical oncology,Vol. 16,No. 3,p. 244-9,2011年06月,研究論文(学術雑誌)
  • Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure.,Koichi Azuma,Junji Tsurutani,Kazuko Sakai,Hiroyasu Kaneda,Yasuhito Fujisaka,Masayuki Takeda,Masahiro Watatani,Tokuzo Arao,Taroh Satoh,Isamu Okamoto,Takayasu Kurata,Kazuto Nishio,Kazuhiko Nakagawa,Biochemical and biophysical research communications,Vol. 407,No. 1,p. 219-24,2011年04月01日,研究論文(学術雑誌)
  • [A review of FOLFOXIRI chemotherapy for the 1st line treatment of metastatic colorectal cancer].,Hisato Kawakami,Taroh Satoh,Kazuhiko Nakagawa,Nihon rinsho. Japanese journal of clinical medicine,Vol. 69 Suppl 3,p. 439-45,2011年04月,研究論文(学術雑誌)
  • Paclitaxel療法後Docetaxel療法を行った進行再発胃癌14例の検討,工藤 敏啓,佐藤 太郎,川上 尚人,上田 眞也,宮崎 昌樹,藤阪 保人,鶴谷 純司,倉田 宝保,岡本 勇,中川 和彦,日本胃癌学会総会記事,(一社)日本胃癌学会,Vol. 83回,p. 188-188,2011年03月
  • Does 1 year adjuvant chemotherapy with oral 5-FUs in colon cancer reduce the peak of recurrence in 1 year and provide long-term OS benefit?,Chikuma Hamada,Junichi Sakamoto,Taroh Satoh,Sotaro Sadahiro,Hideyuki Mishima,Kenichi Sugihara,Shigetoyo Saji,Naohiro Tomita,Japanese journal of clinical oncology,Vol. 41,No. 2,p. 299-302,2011年02月,研究論文(学術雑誌)
  • Multicentre phase II study of XELOX with bevacizumab in late-stage elderly patients with unresectable advanced/recurrent colorectal cancer: an ASCA study.,Koji Oba,Masaki Matsuoka,Taroh Satoh,Kei Muro,Noboru Oriuchi,Junichi Sakamoto,Hideyuki Mishima,Japanese journal of clinical oncology,Vol. 41,No. 1,p. 134-8,2011年01月,研究論文(学術雑誌)
  • Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.,Isamu Okamoto,Masaki Miyazaki,Ryotaro Morinaga,Hiroyasu Kaneda,Shinya Ueda,Yoshikazu Hasegawa,Taroh Satoh,Akira Kawada,Masahiro Fukuoka,Koichi Fukino,Takahiko Tanigawa,Kazuhiko Nakagawa,Investigational new drugs,Vol. 28,No. 6,p. 844-53,2010年12月,研究論文(学術雑誌)
  • 進行肺腺癌を対象としたゲフィチニブ/S-1併用療法第I相臨床試験,清田 秀美,岡本 勇,田中 薫,林 秀敏,寺嶋 応顕,東 公一,武田 真幸,米坂 仁雄,藤坂 保仁,鶴谷 純司,宮崎 昌樹,佐藤 太郎,倉田 宝保,中川 和彦,駄賀 晴子,武田 晃司,内藤 立暁,山本 信之,肺癌,(NPO)日本肺癌学会,Vol. 50,No. 5,p. 502-502,2010年10月
  • Phase I safety, pharmacokinetic, and biomarker study of BIBF 1120, an oral triple tyrosine kinase inhibitor in patients with advanced solid tumors.,Isamu Okamoto,Hiroyasu Kaneda,Taroh Satoh,Wataru Okamoto,Masaki Miyazaki,Ryotaro Morinaga,Shinya Ueda,Masaaki Terashima,Asuka Tsuya,Akiko Sarashina,Koichi Konishi,Tokuzo Arao,Kazuto Nishio,Rolf Kaiser,Kazuhiko Nakagawa,Molecular cancer therapeutics,Vol. 9,No. 10,p. 2825-33,2010年10月,研究論文(学術雑誌)
  • 外来化学療法は安全に施行可能である,藤阪 保仁,林 秀敏,清田 秀美,牧村 ちひろ,田中 薫,武田 真幸,東 公一,上田 眞也,米阪 仁雄,宮崎 昌樹,鶴谷 純司,佐藤 太郎,岡本 勇,倉田 宝保,中川 和彦,日本癌治療学会誌,(一社)日本癌治療学会,Vol. 45,No. 2,p. 582-582,2010年09月
  • 根治切除・照射不能進行食道がんに対する化学療法と局所食道放射線併用療法,上田 眞也,佐藤 太郎,川上 尚人,田中 薫,林 秀敏,清田 秀美,武田 真幸,東 公一,米坂 仁雄,藤阪 保仁,鶴谷 純司,宮崎 昌樹,岡本 勇,倉田 宝保,中川 和彦,日本癌治療学会誌,(一社)日本癌治療学会,Vol. 45,No. 2,p. 990-990,2010年09月
  • Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study).,Kei Muro,Narikazu Boku,Yasuhiro Shimada,Akihito Tsuji,Shinichi Sameshima,Hideo Baba,Taroh Satoh,Tadamichi Denda,Kenji Ina,Tomohiro Nishina,Kensei Yamaguchi,Hiroya Takiuchi,Taito Esaki,Shinya Tokunaga,Hiroyuki Kuwano,Yoshito Komatsu,Masahiko Watanabe,Ichinosuke Hyodo,Satoshi Morita,Kenichi Sugihara,The Lancet. Oncology,Vol. 11,No. 9,p. 853-60,2010年09月,研究論文(学術雑誌)
  • Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.,Yung-Jue Bang,Eric Van Cutsem,Andrea Feyereislova,Hyun C Chung,Lin Shen,Akira Sawaki,Florian Lordick,Atsushi Ohtsu,Yasushi Omuro,Taroh Satoh,Giuseppe Aprile,Evgeny Kulikov,Julie Hill,Michaela Lehle,Josef Rüschoff,Yoon-Koo Kang,Lancet (London, England),Vol. 376,No. 9742,p. 687-97,2010年08月28日,研究論文(学術雑誌)
  • 進行肺腺癌を対象としたゲフィチニブ/S-1併用療法第I相臨床試験,清田 秀美,岡本 勇,谷崎 潤子,文田 壮一,岡本 邦男,牧村 ちひろ,竹澤 健,田中 薫,林 秀敏,岡本 渉,寺嶋 応顕,東 公一,金田 裕靖,武田 真幸,上田 眞也,米坂 仁雄,藤坂 保仁,鶴谷 純司,宮崎 昌樹,佐藤 太郎,倉田 宝保,中川 和彦,駄賀 晴子,武田 晃司,肺癌,(NPO)日本肺癌学会,Vol. 50,No. 4,p. 400-400,2010年08月
  • Disturbance of the growth hormone-insulin-like growth factor-1 axis associated with poor performance status in patients with solid tumors.,Isamu Okamoto,Masaki Munakata,Masaki Miyazaki,Taroh Satoh,Takenori Takahata,Yasushi Takamatsu,Osamu Muto,Kazuhiko Koike,Kunihiko Ishitani,Taketo Mukaiyama,Yuh Sakata,Kazuhiko Nakagawa,Kazuo Tamura,Japanese journal of clinical oncology,Vol. 40,No. 3,p. 222-6,2010年03月,研究論文(学術雑誌)
  • Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent D-19575 (glufosfamide) in patients with solid tumors.,Toshio Shimizu,Isamu Okamoto,Kenji Tamura,Taroh Satoh,Masaki Miyazaki,Yusaku Akashi,Tomohiro Ozaki,Masahiro Fukuoka,Kazuhiko Nakagawa,Cancer chemotherapy and pharmacology,Vol. 65,No. 2,p. 243-50,2010年01月,研究論文(学術雑誌)
  • 高齢者限局型小細胞肺癌に対する化学療法と胸部放射線加速過分割照射同時併用療法の検討,岡本 邦男,岡本 勇,武田 真幸,市川 靖子,上田 眞也,鶴谷 純司,宮崎 昌樹,佐藤 太郎,中川 和彦,西村 恭昌,肺癌,(NPO)日本肺癌学会,Vol. 49,No. 4,p. 523-524,2009年08月
  • Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors.,Taroh Satoh,Isamu Okamoto,Masaki Miyazaki,Ryotaroh Morinaga,Asuka Tsuya,Yoshikazu Hasegawa,Masaaki Terashima,Shinya Ueda,Masahiro Fukuoka,Yutaka Ariyoshi,Toshikazu Saito,Noriyuki Masuda,Hirokazu Watanabe,Tetsuo Taguchi,Toru Kakihara,Yumiko Aoyama,Yohko Hashimoto,Kazuhiko Nakagawa,Clinical cancer research : an official journal of the American Association for Cancer Research,Vol. 15,No. 11,p. 3872-80,2009年06月01日,研究論文(学術雑誌)
  • A phase I study of topotecan plus carboplatin for relapsed SCLC: WJTOG trial.,Takayasu Kurata,Tatsuhiko Kashii,Koji Takeda,Nobuhiko Seki,Masahiro Tsuboi,Masashi Kobayashi,Taroh Satoh,Kazuhiko Nakagawa,Masahiro Fukuoka,Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,Vol. 4,No. 5,p. 644-8,2009年05月,研究論文(学術雑誌)
  • On the path to standardizing esophageal cancer treatment in Japan.,Taroh Satoh,Yuh Sakata,Gastrointestinal cancer research : GCR,Vol. 3,No. 2,p. 77-9,2009年03月,研究論文(学術雑誌)
  • Multicenter Phase II study of cetuximab plus irinotecan in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin and fluoropyrimidines.,Makoto Tahara,Kuniaki Shirao,Narikazu Boku,Kensei Yamaguchi,Yoshito Komatsu,Yoshitaka Inaba,Tatsuhiro Arai,Nobuyuki Mizunuma,Taroh Satoh,Hiroya Takiuchi,Tomohiro Nishina,Yuh Sakata,Japanese journal of clinical oncology,Vol. 38,No. 11,p. 762-9,2008年11月,研究論文(学術雑誌)
  • 腫瘍緊急症について,文田 壮一,森永 亮太郎,岡本 邦男,竹澤 健,岡本 渉,上田 眞也,宮崎 昌樹,鶴谷 純司,佐藤 太郎,岡本 勇,中川 和彦,近畿大学医学雑誌,近畿大学医学会,Vol. 33,No. 3,p. 247-250,2008年09月
  • Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.,Takeshi Yoshida,Isamu Okamoto,Takafumi Okabe,Tsutomu Iwasa,Taroh Satoh,Kazuto Nishio,Masahiro Fukuoka,Kazuhiko Nakagawa,International journal of cancer,Vol. 122,No. 7,p. 1530-8,2008年04月01日,研究論文(学術雑誌)
  • Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase.,Takafumi Okabe,Isamu Okamoto,Sayaka Tsukioka,Junji Uchida,Tsutomu Iwasa,Takeshi Yoshida,Erina Hatashita,Yuki Yamada,Taroh Satoh,Kenji Tamura,Masahiro Fukuoka,Kazuhiko Nakagawa,Molecular cancer therapeutics,Vol. 7,No. 3,p. 599-606,2008年03月,研究論文(学術雑誌)
  • Epoetin beta subcutaneous administration to lung cancer patients with anemia; results of pharmacokinetics/pharmacodynamics study,Kazuhiko Nakagawa,Tomohiro Ozaki,Taroh Satoh,Masaki Miyazaki,Yusaku Akashi,Masaaki Terashima,Yasuhito Fujisaka,Tomohide Tamura,Masahiro Fukuoka,Nagahiro Saijo,Japanese Journal of Lung Cancer,Vol. 47,No. 4,p. 313-322,2007年08月,研究論文(学術雑誌)
  • Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses.,Kenji Tamura,Kazuhiko Nakagawa,Takayasu Kurata,Taroh Satoh,Toshiji Nogami,Koji Takeda,Shigeki Mitsuoka,Naruo Yoshimura,Shinzoh Kudoh,Shunichi Negoro,Masahiro Fukuoka,Cancer chemotherapy and pharmacology,Vol. 60,No. 2,p. 285-93,2007年07月,研究論文(学術雑誌)
  • Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experience.,Toshio Shimizu,Taroh Satoh,Kenji Tamura,Tomohiro Ozaki,Isamu Okamoto,Masahiro Fukuoka,Kazuhiko Nakagawa,International journal of clinical oncology,Vol. 12,No. 3,p. 218-23,2007年06月,研究論文(学術雑誌)
  • Down-regulation of survivin by ultraviolet C radiation is dependent on p53 and results in G(2)-M arrest in A549 cells.,Masato Ikeda,Isamu Okamoto,Kenji Tamura,Taroh Satoh,Kimio Yonesaka,Masahiro Fukuoka,Kazuhiko Nakagawa,Cancer letters,Vol. 248,No. 2,p. 292-8,2007年04月18日,研究論文(学術雑誌)
  • Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification.,Takafumi Okabe,Isamu Okamoto,Kenji Tamura,Masaaki Terashima,Takeshi Yoshida,Taroh Satoh,Minoru Takada,Masahiro Fukuoka,Kazuhiko Nakagawa,Cancer research,Vol. 67,No. 5,p. 2046-53,2007年03月01日,研究論文(学術雑誌)
  • Pemetrexed-induced edema of the eyelid.,Takayasu Kurata,Kenji Tamura,Isamu Okamoto,Taroh Satoh,Kazuhiko Nakagawa,Masahiro Fukuoka,Lung cancer (Amsterdam, Netherlands),Vol. 54,No. 2,p. 241-2,2006年11月,研究論文(学術雑誌)
  • Is the importance of achieving stable disease different between epidermal growth factor receptor tyrosine kinase inhibitors and cytotoxic agents in the second-line setting for advanced non-small cell lung cancer?,Takayasu Kurata,Keitaro Matsuo,Minoru Takada,Masaaki Kawahara,Masahiro Tsuji,Yuka Matsubara,Nagahiro Otani,Shigeki Matsuyama,Kenya Muraishi,Tetsuya Fujita,Masato Ishikawa,Keita Koyano,Isamu Okamoto,Taroh Satoh,Kenji Tamura,Kazuhiko Nakagawa,Masahiro Fukuoka,Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,Vol. 1,No. 7,p. 684-91,2006年09月,研究論文(学術雑誌)
  • Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).,Shinzoh Kudoh,Koji Takeda,Kazuhiko Nakagawa,Minoru Takada,Nobuyuki Katakami,Kaoru Matsui,Tetsu Shinkai,Toshiyuki Sawa,Isao Goto,Hiroshi Semba,Takashi Seto,Masahiko Ando,Taroh Satoh,Naruo Yoshimura,Shunichi Negoro,Masahiro Fukuoka,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,Vol. 24,No. 22,p. 3657-63,2006年08月01日,研究論文(学術雑誌)
  • Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin.,Kimio Yonesaka,Kenji Tamura,Takayasu Kurata,Taroh Satoh,Masato Ikeda,Masahiro Fukuoka,Kazuhiko Nakagawa,International journal of cancer,Vol. 118,No. 4,p. 812-20,2006年02月15日,研究論文(学術雑誌)
  • Inhibition of focal adhesion kinase by antisense oligonucleotides enhances the sensitivity of breast cancer cells to camptothecins.,Taroh Satoh,Tatiana A Surmacz,Okot Nyormoi,Cecilia M Whitacre,Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al,Vol. 27,No. 1,p. 47-55,2003年04月,研究論文(学術雑誌)
  • Photodynamic therapy of human breast cancer xenografts lacking caspase-3.,Cecilia M Whitacre,Taroh Satoh,Liang yan Xue,Nahida H Gordon,Nancy L Oleinick,Cancer letters,Vol. 179,No. 1,p. 43-9,2002年05月08日,研究論文(学術雑誌)

MISC

  • A phase II trial of low-dose nab-paclitaxel for patients with previously treated or recurrent advanced gastric cancer (OGSG1302),Masashi Hirota,Shigeyuki Tamura,Hirokazu Taniguchi,Atsushi Takeno,Hiroshi Imamura,Junya Fujita,Jin Matsuyama,Yutaka Kimura,Junji Kawada,Motohiro Hirao,Kazuhiro Nishikawa,Kazumasa Fujitani,Yukinori Kurokawa,Daisuke Sakai,Hisato Kawakami,Toshio Shimokawa,Taroh Satoh,JOURNAL OF CLINICAL ONCOLOGY,AMER SOC CLINICAL ONCOLOGY,Vol. 38,No. 4,2020年02月,研究発表ペーパー・要旨(国際会議)
  • Comparing five-weekly S-1 plus cisplatin with tri-weekly capecitabine plus cisplatin in patients with HER2-negative recurrent gastric cancer after S-1 adjuvant therapy or chemotherapy naive advanced gastric cancer: A pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials,Jin Matsuyama,Hisato Kawakami,Kazumasa Fujitani,Yusuke Akamaru,Shigeyuki Tamura,Shunji Endo,Yutaka Kimura,Youichi Makari,Takao Tamura,Naotoshi Sugimoto,Daisuke Sakai,Toshimasa Tsujinaka,Masahiro Goto,Yukinori Kurokawa,Toshio Shimokawa,Taroh Satoh,JOURNAL OF CLINICAL ONCOLOGY,AMER SOC CLINICAL ONCOLOGY,Vol. 38,No. 4,2020年02月,研究発表ペーパー・要旨(国際会議)
  • Phase II study of panitumumab monotherapy in chemotherapy-naive frail or elderly patients with unresectable, RAS wild-type colorectal cancer: OGSG 1602,Katsuya Ohta,Takeshi Kato,Masahiro Goto,Tetsuji Terazawa,Shingo Noura,Hironaga Satake,Yoshinori Kagawa,Hisato Kawakami,Hiroko Hasegawa,Kazuhiro Yanagihara,Tatsushi Shingai,Ken Nakata,Masahito Kotaka,Masayuki Hiraki,Ken Konishi,Shiro Nakae,Daisuke Sakai,Yukinori Kurokawa,Toshio Shimokawa,Taroh Satoh,JOURNAL OF CLINICAL ONCOLOGY,AMER SOC CLINICAL ONCOLOGY,Vol. 38,No. 4,2020年02月,研究発表ペーパー・要旨(国際会議)
  • A dose-finding study for irinotecan, cisplatin, and S-1 (IPS) in patients with advanced gastric cancer (OGSG 1106).,Hiroki Yukami,Masahiro Goto,Takayuki Kii,Tetsuji Terazawa,Toshifumi Yamaguchi,Fukutaro Shimamoto,Hitoshi Nishitani,Hisato Kawakami,Toshio Shimokawa,Yoshihiro Matsubara,Daisuke Sakai,Yukinori Kurokawa,Taroh Satoh,JOURNAL OF CLINICAL ONCOLOGY,AMER SOC CLINICAL ONCOLOGY,Vol. 37,No. 4,2019年02月,研究発表ペーパー・要旨(国際会議)
  • An intergroup phase III trial of ramucirumab plus irinotecan in third or more line beyond progression after ramucirumab for advanced gastric cancer (RINDBeRG trial).,Daisuke Sakai,Narikazu Boku,Yasuhiro Kodera,Yoshito Komatsu,Masashi Fujii,Satoru Iwasa,Eiji Oki,Wasaburo Koizumi,Makio Gamoh,Kei Muro,Toshio Shimokawa,Taroh Satoh,JOURNAL OF CLINICAL ONCOLOGY,AMER SOC CLINICAL ONCOLOGY,Vol. 36,No. 15,2018年05月,研究発表ペーパー・要旨(国際会議)
  • Randomized phase II study to compare docetaxel plus S-1 with cisplatin plus S-1 in advanced gastric cancer without measurable lesions (HERBIS-3),Jin Matsuyama,Yukinori Kurokawa,Kazuhiro Nishikawa,Yutaka Kimura,Atsushi Takeno,Junji Kawada,Ryohei Kawabata,Youichi Makari,Shigeyuki Tamura,Yuichiro Doki,Daisuke Sakai,Toshio Shimokawa,Taroh Satoh,JOURNAL OF CLINICAL ONCOLOGY,AMER SOC CLINICAL ONCOLOGY,Vol. 36,No. 4,2018年02月,研究発表ペーパー・要旨(国際会議)
  • Randomized, open-label, phase II study comparing five-weekly S-1 plus cisplatin (SP) with tri-weekly capecitabine plus cisplatin (XP) in chemotherapy-naive patients with HER2 negative advanced gastric cancer (AGC): OGSG 1105 HERBIS-4A trial,Atsushi Takeno,Youichi Makari,Shunji Endo,Jin Matsuyama,Ryohei Kawabata,Naotoshi Sugimoto,Hirokazu Taniguchi,Kenichi Nagai,Shigeyuki Tamura,Junichi Nishijima,Shugo Ueda,Yutaka Kimura,Takao Tamura,Kenji Kobayashi,HIsato Kawakami,Kazumasa Fujitani,Daisuke Sakai,Toshio Shimokawa,Yukinori Kurokawa,Taroh Satoh,JOURNAL OF CLINICAL ONCOLOGY,AMER SOC CLINICAL ONCOLOGY,Vol. 36,No. 4,2018年02月,研究発表ペーパー・要旨(国際会議)
  • Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002),Kawabata Ryohei,Fujitani Kazumasa,Tamura Shigeyuki,Kimura Yutaka,Imamura Hiroshi,Fujita Junya,Matsuyama Jin,Iijima Shohei,Ueda Shugo,Kurokawa Yukinori,Sakai Daisuke,Shimokawa Toshio,Tsujinaka Toshimasa,Furukawa Hiroshi,Satoh Taroh,ANNALS OF ONCOLOGY,OXFORD UNIV PRESS,Vol. 28,2017年06月,研究発表ペーパー・要旨(国際会議)
  • A phase II study to examine the effectiveness of nutritional support with elemental diet for stage II/III gastric cancer patients receiving adjuvant chemotherapy with S-1 (OGSG 1108).,Junji Kawada,Hiroshi Imamura,Jin Matsuyama,Junichi Fukui,Kazuhiro Nishikawa,Tomono Kawase,Toshio Shimokawa,Yukinori Kurokawa,Taroh Satoh,Hiroshi Furukawa,JOURNAL OF CLINICAL ONCOLOGY,AMER SOC CLINICAL ONCOLOGY,Vol. 35,No. 4,2017年02月,研究発表ペーパー・要旨(国際会議)
  • Phase II study of S-1 plus docetaxel as first-line treatment for elderly patients with advanced gastric cancer (OGSG0902).,Jin Matsuyama,Hiroshi Imamura,Ryohei Kawabata,Tomono Kawase,Kazuyuki Okada,Kazuhiro Nishikawa,Yukinori Kurokawa,Kazumasa Fujitani,Toshio Shimokawa,Taroh Satoh,JOURNAL OF CLINICAL ONCOLOGY,AMER SOC CLINICAL ONCOLOGY,Vol. 35,No. 4,2017年02月,研究発表ペーパー・要旨(国際会議)
  • ミトコンドリアC1代謝を標的とした新規抗癌剤のシステム的創薬展開,浅井 歩,小関 準,今野 雅允,西田 尚弘,川本 弘一,三代 雅明,野口 幸蔵,佐藤 太郎,土岐 雄一郎,森 正樹,石井 秀始,ハイパフォーマンスコンピューティングと計算科学シンポジウム論文集,No. 2016,p. 53-53,2016年05月30日
  • A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer: OGSG1203 (HERBIS-5).,Kazuhiro Nishikawa,Daisuke Sakai,Junji Kawada,Ryohei Kawabata,Tomono Kawase,Yoshio Oka,Naotoshi Sugimoto,Takeshi Shimizu,Junichi Nishijima,Hiroko Hasegawa,Shunji Endo,Yutaka Isozaki,Yutaka Kimura,Jin Matsuyama,Yukinori Kurokawa,Toshio Shimokawa,Kazumasa Fujitani,Taroh Satoh,JOURNAL OF CLINICAL ONCOLOGY,AMER SOC CLINICAL ONCOLOGY,Vol. 34,No. 4,2016年02月,研究発表ペーパー・要旨(国際会議)
  • Phase 1 study of preoperative radiotherapy combined with S-1 plus cisplatin in clinically resectable type 4 or large type 3 gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG1205).,Masaki Yokokawa,Motohiro Imano,Hiroshi Furukawa,Yasumasa Nishimura,Yukinori Kurokawa,Taroh Satoh,Daisuke Sakai,Takushi Yasuda,Haruhiko Imamoto,Toshimasa Tsujinaka,Toshio Shimokawa,Hitoshi Shiozaki,JOURNAL OF CLINICAL ONCOLOGY,AMER SOC CLINICAL ONCOLOGY,Vol. 33,No. 15,2015年05月,研究発表ペーパー・要旨(国際会議)
  • A randomized phase II factorial design trial of CPT-11 versus PTX versus each combination with S-1 in patients with advanced gastric cancer refractory to S-1: Final results of OGSG0701.,Kazuhiro Nishikawa,Hiroshi Imamura,Tomono Kawase,Masahiro Gotoh,Yutaka Kimura,Shugo Ueda,Jin Matsuyama,Junji Kawada,Naotoshi Sugimoto,Junya Fujita,Takao Tamura,Norimasa Fukushima,Daisuke Sakai,Toshio Shimokawa,Yukinori Kurokawa,Taroh Satoh,Toshimasa Tsujinaka,Hiroshi Furukawa,JOURNAL OF CLINICAL ONCOLOGY,AMER SOC CLINICAL ONCOLOGY,Vol. 33,No. 3,2015年01月,研究発表ペーパー・要旨(国際会議)
  • Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 1002),Jin Matsuyama,Kazumasa Fujitani,Shigeyuki Tamura,Yutaka Kimura,Hiroshi Imamura,Junya Fujita,Shohei Iljima,Shugo Ueda,Toshio Shimokawa,Yukinori Kurokawa,Taroh Satoh,Toshimasa Tsujinaka,Hiroshi Furukawa,JOURNAL OF CLINICAL ONCOLOGY,AMER SOC CLINICAL ONCOLOGY,Vol. 32,No. 15,2014年05月,研究発表ペーパー・要旨(国際会議)
  • A phase II study of panitumumab plus irinotecan for metastatic colorectal cancer with wild KRAS, resistant to fluoropyrimidine, oxaliplatin, and irinotecan in Japanese (OGSG1001).,Koichi Taira,Motoki Yoshida,Naotoshi Sugimoto,Takayuki Kii,Shin Kuwakado,Mutsumi Fukunaga,Hiroko Hasegawa,Takeshi Kato,Yasuhiro Miyake,Taishi Hata,Yukihiko Tokunaga,Koji Takeda,Haruko Daga,Tetsuhiro Yoshinami,Toshio Shimokawa,Daisuke Sakai,Yukinori Kurokawa,Taroh Satoh,Toshimasa Tsujinaka,Hiroshi Furukawa,JOURNAL OF CLINICAL ONCOLOGY,AMER SOC CLINICAL ONCOLOGY,Vol. 32,No. 3,2014年01月,研究発表ペーパー・要旨(国際会議)
  • イマチニブ耐性GISTに対しスニチニブを使用した4例の経験,川上尚人,佐藤太郎,上田眞也,工藤敏啓,岡本勇,倉田宝保,鶴谷純司,宮崎昌樹,藤阪保仁,中川和彦,日本消化管学会総会学術集会プログラム・抄録集,Vol. 7th,2011年
  • 胃癌に対する抗体療法 (特集 消化器癌の分子標的治療),川上 尚人,佐藤 太郎,消化器内科,科学評論社,Vol. 51,No. 1,p. 91-98,2010年07月
  • 当院における肺門・縦隔病変に対するコンベックス走査式超音波気管支鏡ガイド下生検検討,宮崎昌樹,文田荘一,寺嶋応顕,武田真幸,清水俊雄,市川靖子,米阪仁雄,鶴谷純二,佐藤太郎,岡本勇,岡本勇,福岡正博,中川和彦,気管支学,Vol. 31,2009年
  • 貧血を伴う肺癌患者におけるEpoetin beta皮下投与の薬物動態の検討,尾崎智博,中川和彦,野上壽二,佐藤太郎,池田昌人,寺嶋応顕,藤阪保仁,田村友秀,福岡正博,西條長宏,日本臨床腫瘍学会学術集会プログラム・抄録集,Vol. 4th,2006年